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ABSTRACT OF THE DISSERTATION 
A Longitudinal Investigation of the Relationships amongst Antibody Response to Influenza 
Vaccination, Affect, and Stress in the Elderly 
by JOANNE M. HASH-CONVERSE 
Dissertation Director:  
Professor Alexander Kusnecov 
  
We examined the cross-sectional and longitudinal relationships amongst affect, stress 
exposure, and antibody (Ab) response to influenza inoculation in a healthy, elderly sample. 
We explored both efferent (CNS on immune activity) and afferent (immune activity on CNS 
function) pathways. Negative (NA) and positive (PA) affective states were examined in 
relation to Ab response, positing that high baseline NA (State, SNA, but not Trait, TNA) 
would predict reduced Ab response and that PA would predict enhanced response, and that 
the reduced Ab response in individuals displaying high baseline SNA would associate with 
decreases in NA. Moderator (for psychogenic and systemic stress) and mediator (systemic 
symptom reporting) tests were conducted to validate these relationships.  
 The 152 (97 female, 55 male; age M=72.49, SD=6.32) participants were residents of 
a retirement community, who met medical exclusionary criteria and completed all three 
annual assessments (in 1992, 1993, and 1996). Participants were inoculated with trivalent 
influenza vaccine, and Ab titer was assayed two weeks post-inoculation via hemagglutinin 
inhibition assay.  
 As hypothesized, TNA did not predict Ab response. Surprisingly, high baseline SNA 
predicted enhanced Ab response, which predicted decreased NA in a year- and strain-specific 
manner. Longitudinally, robust initial Ab response followed by steady decreases was 
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associated with combinations of no change in one dimension of NA and decreases in the 
other. High PA only showed transient associations with increased Ab response. Stress did 
not act as a moderator, though systemic symptom reporting did mediate the relationship 
between Ab response and change in NA in 1996. 
 Overall findings suggest a reconceptualization of initial NA. High levels of initial 
SNA did not predict impaired immunity, but instead robust response. Hence, instead of an 
aberrant affective state, high initial SNA likely indicates enhanced arousal, which returns to 
lower levels after threat ceases. This study also illustrates the complexities involved in 
investigating the relationship between health and immunity, and importantly sheds light on 
how varying temporal and antigenic variables may elicit differences. This study adds 
considerably to the body of work exploring the dynamic interplay between emotion, 
experience, aging, and physiological response to benign immune challenge.   
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INTRODUCTION 
 The concept of mind-body connectivity is an ancient one, espoused in disciplines 
ranging from spirituality (e.g., the tenets of Buddhism of 200 B.C.E) to science and medicine 
(e.g., Greek physician Galen). However, in medicine the prevailing model was of a mind 
orchestrating physiology and corporal sensations being processed by a receptive mind. The 
concept of true bidirectional communication was not fully recognized until quite recently. 
The field of Psychoneuroimmunology (PNI) was bourn of the need to empirically 
investigate the mechanisms underlying mind-body interactions, and the pathways by which 
these interactions occurred. Since its inception in 1930, PNI has made great strides in 
elucidating both the efferent and afferent pathways between the central nervous system 
(CNS) and the immune system. To briefly illustrate some major lines of evidence for this 
interaction: hormones influence expression of Major Histocompatibility Complex (MHC) 
class (Muller and Ackenheil, 1998), immune products influence neurotransmitter activity 
(Muller and Ackenheil, 1998), cytokine receptors are found in the brain (Parnet et al., 2002), 
many psychiatric disorders parallel autoimmune development and pathology (Muller and 
Ackenheil, 1998), neuro-endocrine and immune products coexist in lymphoid, endocrine, 
and neural tissue (Besedovsky and DelRey, 1996) (see Figure 1 for a schematic 
representation of neuro-endocrine-immune interactions).  
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Efferent Pathways from CNS to Immune System 
 There are four primary routes by which the CNS efferently influences immune 
function: peripheral nervous system, sympathetic nervous system (via adrenergic 
mechanisms), parasympathetic nervous system (via cholinergic mechanisms), and 
neuroendocrine mechanisms (i.e., the hypothalamic-pituitary-adrenal [HPA] axis) (Sternberg, 
2006). While the peripheral nervous system acts mainly in a localized fashion to promote 
inflammation at the beginning of pathogen invasion (though essential in the regulation of 
immunity, peripheral nervous system mechanisms will not be extensively discussed herein; 
for a review, see Sternberg 2006), the other routes act primarily in a regulatory capacity not 
only to facilitate clearance of pathogen but also to reign in the immune response itself. The 
autonomic nervous system components achieve this via direct innervation of immune organs, 
while the HPA axis does so systemically by stimulating production of anti-inflammatory 
glucocorticoids (Sternberg, 2006).  
 
HPA Axis  
 Exposure to stress, be it psychological events or physiological insults (i.e., release of 
interleukin (IL)-1 subsequent to pathogen invasion), triggers the HPA axis via release of 
corticotropin-releasing hormone (CRH) from the hypothalamic paraventricular nucleus 
(Steinman, 2004). Corticotropin-releasing hormone then stimulates the anterior pituitary to 
secrete adrenocorticotropic hormone (ACTH), resulting in glucocorticoid synthesis and 
release from the adrenal cortex (Steinman, 2004). Glucocorticoids generally serve as a 
negative feedback mechanism to reign in an immune response, such that immune cells with 
highest affinity for the pathogen are selected for while reducing non-specific immune cells 
which could result in immunopathology, potentially providing enhanced efficacy of the 
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immune response (Besedovsky and del Rey, 2007). In a further regulatory capacity, 
glucocorticoids downregulate production of proinflammatory mediators (i.e., cytokines) to 
prevent development of life-threatening sepsis (Besedovsky and del Rey, 2007). 
Glucocorticoids also act to inhibit the HPA axis itself, in order to ensure complete clearance 
of the pathogen. Excessive glucocorticoid circulation has been associated with impaired 
ability to clear viral infections (Glaser and Kiecolt-Glaser, 2005; Glaser et al., 2005) and 
decreased antibody response subsequent to vaccination (Vedhara et al., 1999). 
Glucocorticoids can also influence antibody class switching between Immunoglobulin (Ig)M 
and IgG (Elliott and Sinclair, 1968), and there is an inverse relationship between 
glucocorticoids and splenic Ab production, further indicating the effect of endogenous 
glucocorticoids on B cell function (del Rey et al., 1984). Hence, a delicate balance of HPA 
axis activation must occur to optimize the immune response and return the organism to 
homeostasis. The HPA axis acts as the primary means by which hormones influence 
immunity. However, the sympathetic nervous system (SNS) also releases adrenaline from the 
adrenal medulla to regulate immune activity. 
 
Sympathetic Nervous System  
 Adrenaline release from SNS activation systemically reduces circulating immune cells 
(i.e., monocytes, B and T cells, Natural Killer [NK] cells) through cell surface-expression of 
β-adrenergic receptors (Vedhara et al., 1999). Beta-adrenergic receptor stimulation also 
suppresses lymphocyte proliferation (Muller and Ackenheil, 1998), and β-adrenergic 
agonsists reduce IL-2 receptor expression on lymphocytes (Feldman et al., 1987). The SNS 
exerts immunomodulatory activity not only through adrenaline, but also via the 
neurotransmitter noradrenaline. Noradrenergic binding to β-adrenergic receptors results in 
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suppressed pro-inflammatory cytokine production mediated by second messengers (Vedhara 
et al., 1999). As with the HPA axis, the SNS can be stimulated through stress (particularly 
psychological). If of sufficient magnitude, activation of the SNS may release large amounts 
of noradrenaline, which acts immunosuppressively (Sternberg, 1989).  
 
Parasympathetic Nervous System  
 Like the SNS and HPA axis, the parasympathetic nervous system (PNS) provides 
negative feedback subsequent to cytokine release to reign in inflammatory responses. It does 
so through both vagal afferents and the primary PNS neurotransmitter acetylcholine, Ach 
(Sternberg, 2006). The vagus detects presence of peripheral inflammation through 
paraganglia IL-1 receptors, triggering the release of Ach which then inhibits macrophage-
induced pro-inflammatory cytokines (Sternberg, 2006). Acetylcholine receptors are found 
not only on macrophages, but also on T cells and B cells, indicating the diverse effects the 
PNS exerts on the immune system (Sternberg, 2006).  
 
The paradigm behaviorally-conditioned immunosuppression is an elegant example of how 
the CNS directly impacts immune system functioning. Behaviorally-conditioned 
immunosuppression refers to the pairing of immunosuppressive treatment (the 
unconditioned stimulus, US) with a flavored beverage (the conditioned stimulus, CS), 
ultimately resulting in the CS alone eliciting immunosuppressive effects (Ader and Cohen, 
1975). This effect reveals how effectively the immune system communicates with the CNS. 
While this effect may appear to be maladaptive, under certain circumstances suppression of 
the immune system may have beneficial implications. For example, if a non-toxic CS may be 
utilized to reduce the effective dosage of an immunosuppressant, this would have important 
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consequences for the treatment of autoimmune diseases. Indeed, in an animal model of 
lupus, lupus-prone mice can be trained to suppress clinical manifestations of the disease by 
consuming a saccharine solution once paired with the immunosuppressant 
cyclophosphamide (Ader and Cohen, 1982). Extending this, investigations of the 
conditionability of lipopolysaccharide (LPS)-induced endotoxin tolerance have been 
conducted. Using the conditioned taste aversion paradigm, investigators have found that 
after trained associations between a saccharine drinking solution (CS) and small doses of 
LPS (US), the saccharine solution alone was able to induce endotoxin tolerance, as evidenced 
by cessation of LPS-induced tumor necrosis factor (TNF)-α production (Oberbeck et al., 
2003).  
 Although the direct impact of CNS activation (e.g., via neurotransmitters, 
neuropeptides, hormones, neural efferents) had remained controversial for a considerable 
time, recent studies have illustrated quite convincingly the important role of CNS activation 
in a precisely regulated immune response. These efferent CNS influences facilitate the ability 
of the immune system to operate in a carefully orchestrated manner, maintaining 
homeostasis under pathological conditions. 
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Afferent Communication from the Immune System to the CNS 
 Less well-delineated are the mechanisms by which the immune system acts as an 
afferent sensory organ relaying physiological information to the CNS, particularly in 
reference to human behavior. As mentioned in the prior section, vagal afferents transporting 
IL-1 to the hypothalamus are often the first indicator to the CNS of peripheral immune 
activation (Goehler et al., 1999). Hypothalamic stimulation is often one of the first CNS 
effects of immune activation. For example, immunization causes sustained three- to four-
fold elevations in glucocorticoids (Besedovsky and DelRey, 1996; Besedovsky and del Rey, 
2007). Immunoglobulins have been shown to bind, via their Fc region, to ACTH-producing 
cells in the pituitary, illustrating the direct impact of antibodies on the HPA axis (Pouplard et 
al., 1976).  
 Cytokines produced in the periphery can also reach the CNS (via vagal afferents, 
active transport, circumventricular organs) to influence learning, behavior and emotion. The 
presence of cytokine receptors in the CNS also further supports this. The hippocampus and 
hypothalamus are the regions with the greatest expression of cytokine receptors (Rothwell et 
al., 1996; Mehler and Kessler, 1997), indicating the possible influence of cytokines in 
memory, learning, and neuroendocrine states. Interleukin-1 receptors are heavily expressed 
on neurons in the hippocampus (Besedovsky and DelRey, 1996) and hypothalamus, linking 
IL-1 to memory and neuroendocrine functions (Besedovsky and del Rey, 2007). Interleukin-
1 also has an overall effect of tryptophan accumulation in the CNS, and reduces 
noradrenaline content (Besedovsky and del Rey, 2007), implicating this cytokine in emotion 
and arousal. Interleukin-2 receptors also show greater prominence in neurons, particularly in 
hippocampal neurons (Araujo et al., 1989), than in astrocytes or microglia, indicating the 
direct impact of IL-2 on neuronal function (Shimojo et al., 1993). 
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Not only can the immune system exert its effects on the CNS through active 
transport of peripheral cytokines into the CNS across the blood-brain barrier (BBB), but also 
endogenous to the CNS itself are immunocompetent cells – astrocytes and microglia (Xiao 
and Link, 1998; Sredni-Kenigsbuch, 2002). Activated microglia secrete IL-1, IL-2, IL-6, IL-
10, and a small amount of TNFα, while activated astrocytes produce IL-1, IL-6, and TNFα 
(Muller and Ackenheil, 1998; Sredni-Kenigsbuch, 2002). Interestingly, the cell type that 
produces IL-6 is dictated according to stimulation, with TNFα and IL-1 stimulating 
astrocytes (Sawada et al., 1992) and granulocyte-colony stimulating factor inducing microglia 
to secrete IL-6 (Muller and Ackenheil, 1998). Some reports even indicate that neurons 
themselves can produce IL-6 (Schobitz et al., 1992) and TNFα (Gendron et al., 1991; Breder 
et al., 1993). Studies of the sickness behavior have provided a wealth of knowledge on the 
impact of immune activation on behavior and will be briefly reviewed herein. 
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CNS Response to Immune Challenge: Sickness Behavior 
 When an organism is exposed to a pathogen, the result is a constellation of 
physiological and behavioral manifestations, broadly recognized as sickness behavior (Hart, 
1988). Sickness behavior is often characterized by hypophagia, hyperalgesia, lethargy, 
psychomotor retardation, anhedonia, and cognitive impairments, and is considered to be an 
adaptive response allowing the organism to focus its resources toward recovery (Hart, 1988). 
This view has been further expanded to examine sickness behavior as a manifestation of 
adaptive motivational states (Dantzer, 2004). However, when the activation of these systems 
is sustained, the burden may result in an increased vulnerability toward developing other 
pathologies, such as depression (Anisman and Merali, 2003). Many of the symptom 
manifestations of sickness behavior parallel depression (i.e., lethargy, anhedonia, hypophagia) 
and anxiety (i.e., decreased locomotor activity and social interactions) (Anisman and Merali, 
2003). As such, sickness behavior is one of the most useful and direct measures of the 
impact on the CNS and the behavioral sequelae of immune activation. Cytokines, soluble 
mediators of immunocompetent cellular proliferation and differentiation (Capuron et al., 
2000), play a prominent role in the evolution of sickness behavior (Anisman et al., 2005). A 
number of animal and human models of sickness behavior have been developed to elucidate 
the effects of varying immunological challenge on CNS function. 
 
Endotoxin/Lipopolysaccharide  
 Lipopolysaccharide is the pathogenic component produced by gram negative 
Escherichia coli. Challenge with LPS results in a plethora of immune system effects, 
particularly the development of sepsis, which is mediated primarily by proinflammatory 
cytokines such as TNFα, IL-1, and IL-6 (Besedovsky and DelRey, 1996; Oberbeck et al., 
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2003; Dantzer, 2004). This antigen elicits many of the characteristic behavioral effects of 
sickness behavior, such as hypophagia, decreased locomotor activity, weakness (Dantzer, 
2004). The anhedonic effects of LPS administration are one of the key symptoms of 
depression (Anisman and Merali, 2002), and are attenuated by antidepressant treatment 
(Yirmiya, 1996). Thus, exposure to this antigen is considered to represent an animal model 
of depression (Dunn et al., 2005). Yet, the afore-mentioned effect was only observed in rats 
and not in mice (Dunn et al., 2005), indicating that genetic background may play a role in the 
cytokine effects on anhedonia. These behavioral effects of peripherally-administered LPS are 
mediated by neural afferents (Dantzer et al., 1998).  
 Some work has also been conducted on humans to examine the cognitive and 
affective sequelae of endotoxin challenge. Though constrained by the ability to administer 
pathogenic doses in humans, limited work has been done investigating how low-dose in vivo 
endotoxin challenge impacts human emotion and behavior. At a dose of LPS high enough to 
induce cytokine production but not illness, endotoxin-induced cytokine activation has been 
shown to elicit cortisol-independent memory deficits and increased anxiety in healthy young 
men (Reichenberg et al., 2001). The same dose of LPS also results in changes in declarative 
memory depending on degree of IL-6 production, with impaired declarative memory 
following a large increase in IL-6 and improved declarative memory subsequent to a small 
increase in this cytokine (Krabbe et al., 2005), indicating that alterations in memory 
performance are contingent upon robustness of the proinflammatory cytokine response. 
Cohen and collaborators (2003) delved further into endotoxin-induced memory deficits by 
examining whether different types of memory may be affected by low-dose administration of 
LPS. Consistent with Krabbe and colleagues (2005), they found that endotoxin-induced 
cytokine production caused a reduction in declarative memory, however, they found an 
10 
 
unexpected enhancement in working memory (Cohen et al., 2003a). From an evolutionary 
perspective, it may be that forms of memory more salient to an organism's immediate 
survival (i.e., working memory) may be enhanced during immune activation so that limited 
resources can be focused on dealing with urgent stimuli. 
 
Cytokines  
 Activated immune cells synthesize and release cytokines. As discussed in the prior 
sections, induction of cytokines by pathogens can act as potent stimulation of sickness 
behaviors. Direct cytokine administration acts similarly. Furthermore, cytokines have been 
shown to have a role in learning and memory (Dantzer, 2004). The presence of IL-1 
receptors in the dentate gyrus of the hippocampus initiated investigations of the effects of 
proinflammatory cytokines on learning and memory (Dantzer, 2004). For the most part, IL-1 
appears to impair performance on memory tasks such as the Morris water maze (Gibertini et 
al., 1995), contextual fear conditioning (Pugh et al., 2001), and Pavlovian conditioning 
(Aubert et al., 1995). Repeated systemic administration of the cytokine IL-2 also resulted in 
impairments in Morris water maze performance, also suggesting a role in working memory 
for this cytokine (Lacosta et al., 1999). Interleukin-1 administration is also frequently used as 
an animal model of depression, in that it induces many of the sickness behaviors indicative 
of depression (i.e., hypophagia, decreased locomotor activity, anhedonia) (Dunn et al., 2005). 
Through its stimulatory impact on corticotropin-releasing factor, linked to depression and 
anxiety, IL-6 has also been utilized as a model of depression (Juttler et al., 2002). 
Systemic administration of cytokines also has a direct effect on neurotransmitter 
levels (Anisman et al., 2005). Interleukin-1β impacts serotonin (5-HT) turnover in the 
hippocampus, prefrontal cortex, and hypothalamus, as well as increases noradrenaline 
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turnover in key stress structures (Dunn et al., 1999; Brebner et al., 2000). Like IL-1β, TNFα 
administration in the paraventricular nucleus of the hypothalamus resulted in sensitization of 
noradrenaline activity (Hayley et al., 1999), although this finding may be due to TNFα's 
stimulation of IL-1 production (Dunn et al., 2005). Although not as robust as the findings 
regarding IL-1 and TNFα, IL-2 administration also exhibits anhedonic effects (Anisman et al., 
2005), which may be mediated by its inhibitory influence on dopamine (Anisman et al., 1996). 
Moreover, the "depressogenic" effects of IL-1 and IL-6 administration can be attenuated by 
antidepressant treatment (Merali et al., 2003).  
 As with endotoxin challenge, ethical constraints prohibit the administration of large 
doses of cytokines to healthy humans. However, the advent of cytokine-based 
immunotherapy to treat a host of diseases such as cancer, autoimmune disorders, and 
transplant rejection shed further light on the psychological sequelae of immune dysregulation. 
Cytokines (i.e., interferon [IFN], IL-2, TNFα, IL-6), or agents that directly impact cytokines, 
are utilized in the treatment of immune-related disorders due to their potent 
immunomodulatory functions. Cytokines act as the primary signaling source between the 
immune system and CNS (Dantzer et al., 1998), and as stated above are known to alter 
neurotransmitter levels (Anisman and Merali, 1999). It may be these actions that are 
responsible for the neuropsychiatric complications often associated with this type of 
treatment regimen (Anisman et al., 2005). Decreasing IFNγ levels with the use of cyclosporin 
A has been associated with elevated levels of anxiety and depression in transplant patients 
(Kahan et al., 1987). Similarly, treatment of chronic Hepatitis C virus with IFNα resulted in 
increased levels of IL-6, IL-8, and IL-10, and the elevated levels of IL-6 were further 
associated with heightened depression and anxiety two to four weeks after initiation of 
treatment (Bonaccorso et al., 2001). Interferon-alpha, IFNα, has direct influences on the 
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serotonergic system (i.e., increasing 5-HT transporter mRNA [(Morikawa et al., 1998)], 
decreasing brain levels of 5-HT (Kamata et al., 2000), inducing 5-HT catabolism 
(Bonaccorso et al., 2001)); and subsequent studies revealed that the elevated depression 
scores associated with IFNα therapy were also negatively correlated with serum 5-HT levels 
(Bonaccorso et al., 2002; Capuron and Miller, 2004). Although it may seem that the somatic 
effects of treatment and/or illness may be responsible for the affective manifestations, the 
two effects can be dissociated in that the somatic symptoms arise very early and wane while 
the mood-related changes generally appear later (Capuron et al., 2002) and are the only 
symptoms responsive to antidepressant treatment (Musselman et al., 2001). Yet, this 
depressogenic effect of IFNα treatment can be seen as early as three days post-treatment, 
and appears to act synergistically with IL-2 to exaggerate these early effects (Capuron et al., 
2000). Indeed, only when in conjunction with IL-2 are the anxiogenic effects of IFN 
observed so early, although the majority of this effect can be attributed to heightened 
somatic symptoms observed as side effects of treatment itself (Capuron et al., 2000).  
 
Psychological Sequelae of Immune-Related Disease States  
 That depression, anxiety and other affective disorders are often comorbid with 
immune-related disease states (i.e., rheumatoid arthritis, multiple sclerosis, cancer) indicates 
the magnitude of impact immune dysregulation has on CNS states (Marques-Deak et al., 
2005). For example, rheumatoid arthritis has long been associated with major depressive 
disorder, and this association remains even when psychosocial and pain-related factors are 
taken into account (Marques-Deak et al., 2005). Multiple sclerosis also evidences increased 
prevalence of depression (Minden and Schiffer, 1990), and the disease state precedes 
affective abnormalities (Foley et al., 1992). However, it is not only overactivation of the 
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immune system that is associated with depressive symptomatology. Disease states, such as 
Human Immunodeficiency Virus (HIV) and infection, characterized by loss of immune 
function can also be linked to depression (Kopnisky et al., 2004). This points to the 
likelihood that dysregulation of the immune system, rather than static elevation or inhibition, 
is the mediator of affective pathology. 
 These experimental models of the effects of immune challenge illuminate how 
diversely immune products impact CNS states. 
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Bi-directional Communications between the CNS and Immune Systems 
Having reviewed the mechanisms by which the CNS afferently impacts immune 
activation, and by which the immune system communicates with the CNS about 
physiological states, it is important to assert that these pathways do not occur in a vacuum. 
At all times, the two systems interact with one another in a dynamic manner. These complex 
interactions between the central nervous and immune systems are posited to occur via either 
"long loop" or "local" interactions (Besedovsky and del Rey, 2007). The long-loop 
interactions refer to activation of the immune system eliciting production of immune 
products which can then influence the function of distant neuro-endocrine structures 
(Besedovsky and del Rey, 2007). Local interactions are as they would seem, with the co-
existence and co-expression of immune and neuroendocrine factors in the stimulated tissue 
(Besedovsky and del Rey, 2007). Of course, there is no absolute distinction between the two 
pathways, as there will invariably be a great deal of overlapping functionality (see Figure 2). 
Although most studies focus on either the efferent effects of the CNS on immune system 
functioning or afferent affective/cognitive/behavioral consequences of immune activation, 
the present series of studies will examine both seeking to better elucidate the true bi-
directionality that occurs in an interactive, responsive organism. Using influenza vaccination 
as a practical, ecologically relevant model of immune challenge, this study will investigate 
both how affective states and stress impact antibody response to benign immune activation 
and how degree of immune activation will in turn influence affective states. Furthermore, it 
will do so both cross-sectionally and longitudinally to more fully explicate the immediate and 
long-term relationships amongst emotion, immunity, and health. 
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Vaccination and Human Health 
 Examining the psychological sequelae of immune activation as well as the 
psychosocial factors influencing immune responsiveness to vaccination provides an excellent, 
non-invasive in vivo source of evidence for immune-CNS interactions. The advent of 
vaccination in 1796 by Edward Jenner revolutionized human health. Since that time, 
vaccinations have aided in saving countless lives from common ailments, such as influenza. 
Indeed, influenza vaccination has been particularly meaningful for populations at greatest 
risk of disease-related mortality, vis a vis the immunocompromised (e.g., very young, ill, and 
elderly).  
 There are immune changes accompanying not only pathological aging processes, but 
also normal aging processes, which render vaccination crucial in the maintenance of health 
in older individuals. An in vitro comparison of immune function in young, healthy older, and 
individuals with Alzheimer's (DAT), found that in young versus healthy older individuals age 
was associated with decreased basophils (which are known to store anti-inflammatory 
histamine and activate IgE) and reduced proliferation to phytohemagglutinin, PHA (Song et 
al., 1999). However, DAT relative to healthy age-matched controls was associated with 
decreased large unsustained cells, increased monocytes and surprisingly increased 
lymphocyte proliferation to PHA (Song et al., 1999). This illustrates distinctions in immune 
parameter changes between young and normal aging processes, as well as those associated 
with DAT. A four-year longitudinal study of the relationship between depression and 
immunity in a sample of elderly adults living in a retirement community revealed that age 
differences were seen for lymphocytes, CD4+DR+ T-cells, CD8+ T-cells, & CD8+DR+ T-
cells (Fortes et al., 2003). Independent of these differences, people with at least seven 
depressive symptoms had lower percentages of CD4+DR+ T-cells and CD8+DR+ T-cells, 
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indeed for every unit increase in depression there was a 3.72% and 4.11% decrease in these 
cell types, respectively (Fortes et al., 2003). This impaired cellular immunity may lead to 
increased susceptibility to infectious agents, and hence increased mortality. Conversely, 
rumination has been found to be associated with elevated numbers of leukocytes, 
lymphocytes, and CD19+ B lymphocytes (Thomsen et al., 2004). These associations were 
not found in a young sample, providing evidence that psychological states may have a greater 
impact on immunity in the elderly than in young populations (Thomsen et al., 2004). These 
physiological alterations in immunity illuminate the importance of vaccination in a healthy 
elderly sample. 
 While influenza and pneumonia are the fifth-leading cause of death in the over-65 
population, only 68% receive influenza inoculation (Thompson et al., 2004). The three most 
frequent reasons why individuals desist from vaccination were prior adverse reaction, belief 
in unlikelihood of contracting flu, and fear of side effects, the most important of which was 
the first, as it predicted a 15 times greater likelihood of repeated vaccination (Tabbarah et al., 
2005). Given the necessity of influenza vaccination due to altered immunity and the impact 
of psychological states on immune profiles, elucidating factors which may contribute to 
vaccine efficacy and willingness to receive vaccination is crucial. 
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Negative Affect and Response to Vaccination 
 The role of negative affect, NA, often characterized by depressed and/or anxious 
mood, has received much attention in relation to vaccine responsiveness, both symptomatic 
and immunological. Negative affect has been defined as the "general dimension of subjective 
distress and unpleasurable engagement that subsumes a variety of aversive mood states" 
(Watson et al., 1988), p. 1063). Testing the symptom-perception hypothesis, which asserts 
that individuals high in NA direct greater attention to somatic sensations and that they 
misattribute emotional activation to physical symptomatology, Diefenbach et al (1996) 
examined the role of negative affect  in both cross-sectional and longitudinal symptom (local 
and systemic) reports to influenza vaccination in healthy older individuals. Cross-sectionally, 
individuals with high depression reported greater systemic symptoms, consistent with the 
hypothesis and the literature in general (Diefenbach et al., 1996). As expected, local 
symptom reports were not associated with NA, and did increase after active injection, 
reflecting accurate local symptom reports. Contrary to expectations, individuals reported a 
decrease in systemic symptoms two weeks after active inoculation, and furthermore this 
decrease was unrelated to NA (Diefenbach et al., 1996). Yet, there was a trend for 
individuals with high levels of both anxiety and depression to return to baseline levels of 
symptom reports 72 hours after inoculation, whereas all other groups continued to decline. 
Age of participants may have been a factor contributing to lack of associations, as elderly are 
more experienced with somatic activation and are thus likely to be more objective and 
accurate with somatic evaluation, termed the "commonsense framework" (Diefenbach et al., 
1996). Also, the types of immune activation applied here do not induce robust systemic 
symptoms, which would be necessary for increased reporting. As an extension of their prior 
study, Leventhal and colleague (1996) sought to determine whether NA could act as a 
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predictor of somatic symptoms six months after assessment in two cohorts of healthy elderly 
participants. During the first wave, depressed affect predicted greater symptom reports six 
months after assessment, while anxious affect did not (Leventhal et al., 1996). The second 
wave showed even stronger effects. Also, state and trait were distinguishable in that state 
measures consistently showed significant associations, while trait NA did not. This supports 
the notion that state affect is a much better predictor of somatic complaint than is trait 
(Leventhal et al., 1996). Mora and colleagues (2002) extended this work to investigate how 
trait negative affect and self-assessed health relate to acute and chronic symptoms reports, as 
well as reported illness episodes and medical care-seeking in elderly white individuals. 
Furthermore, they sought to test the validity of the symptom perception hypothesis, which 
states that high NA predicts increased vigilance to the internal state manifests as increased 
symptom reporting, in relation to the commonsense framework, which suggests that these 
associations emerge from a reasonable self-awareness (Mora et al., 2002). While trait NA was 
positively and self-assessed health negatively associated with chronic symptom reports 
(primarily in women, which may be due to the somatic distress of osteoarthritis), the data did 
not support the symptom perception hypothesis (Mora et al., 2002). The symptom reports 
accurately reflected individuals' somatic states, which lends credence to the commonsense 
framework, suggesting that elderly individuals' long experience with health changes makes 
them experts in their own somatic states. A placebo-controlled study of the impact of 
depression and anxiety on systemic symptom reporting subsequent to influenza inoculation 
showed that 59% of those with high anxiety reported systemic side effects (versus 34% 
controls) and 73% of those with high depression did the same (relative to 35% of controls), 
and both high anxiety and depression was associated with reduced quality of life (Allsup and 
Gosney, 2002). However, the prevalence of definite anxiety and depression were quite low in 
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this sample, 4% and 1.2% respectively, and thus caution must be used when assessing 
generalizability (Allsup and Gosney, 2002). 
 It is possible that the modest associations between negative affect and symptom 
reporting in healthy older adults is mediated by attenuated physiological response to 
pathogens. The current investigation seeks to clarify this by examining the antibody response 
to influenza vaccination in relation to negative affect and systemic symptom reporting. Trait 
and state affect may represent distinct pathways between emotion and health, with trait 
representing an efferent pathway and state both an efferent baseline reactivity to immediate 
circumstances and an afferent response (i.e., sickness behavior) to immune activation and 
stress. Although trait NA may act as a predisposing efferent factor for state reactivity, the 
stable nature of trait affect makes it likely that the organisms' physiological processes have 
adapted to potential deleterious effects thereby making trait NA a poor predictor of 
physiological variability. Also given trait NA's questionable relatedness to systemic symptom 
reports, we expect no association between trait NA and Ab response, bringing us to the first 
hypothesis. 
H1: Trait negative affect (NA) will have no impact on Ab response to 
influenza inoculation. 
Unlike Trait NA, State NA should more accurately reflect stress reactivity bound to a 
contextual event (i.e., inoculation), and as such should associate with alterations in Ab 
response to inoculation. The psychological stress of inoculation may enhance NA, 
particularly anxious affect at baseline, and the noradrenergic and glucocorticoid effects of 
this heightened stressful state may associate with decreased Ab response. The decreased Ab 
response in individuals with high NA may then result in an alleviation of NA at a follow-up 
time point, from which Hypothesis 2 is derived. 
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H2: State changes (from baseline to two weeks post-inoculation) in NA will 
associate with differential Ab response to influenza vaccination. High 
baseline State NA will associate with decreased Ab response. This attenuated 
Ab response will then lead to reduced NA at follow-up. 
Furthermore, since the psychologically and physiologically stressful effects of inoculation 
will be most intense the first year of inoculation, it is expected that the relationships between 
state NA and Ab response will be less pronounced over the long-term: 
H2a: The relationship between NA and Ab response will be most evident the 
first year of strain exposure, but will remain to a lesser degree over the long-
term. 
  
 Glaser and colleagues have conducted extensive investigations into the relationships 
amongst NA, stress, and immunological vaccine responsiveness. A seminal study by this 
group examined the effects of chronic stress (e.g., caring for a spouse with dementia) on the 
immune response to influenza vaccination in the elderly (Kiecolt-Glaser et al., 1996). In spite 
of similar baseline Ab titers, caregivers showed less responsiveness to vaccination than did 
controls. This was especially evident in the older subgroup. Furthermore, caregivers also 
produced less IL-1β and IL-2 than controls (they differed neither in IL-6, nor in percentages 
of lymphocytes and monocytes). As expected, care-givers had more depressive symptoms 
than controls, though this did not interact with Ab or cytokine measures, suggesting 
dissociation between stress, depression, and immune dysregulation (Kiecolt-Glaser et al., 
1996). Glaser and group (1998) compared both humoral and cellular immune response to 
influenza vaccination in two cohorts of elderly individuals. Two consecutive flu seasons were 
used to assess immune response in current caregivers of spouses with Alzheimer's Disease, 
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former caregivers, and controls for the first season (Glaser et al., 1998). Prior vaccination 
was not controlled for, and more caregivers had received prior inoculations, yet they showed 
poorer baseline immune response than controls as well as impaired cellular and humoral 
response at two weeks (when baseline differences were accounted for). Current and former 
caregivers did not differ from one another. To control for variation in vaccine history, in the 
second cohort, only those who had received inoculation the prior year were included. This 
time, baseline Ab levels did not differ (Glaser et al., 1998). Similar to the prior study, 
caregivers significantly differed in responsiveness to controls, with only 32% of former and 
38% of current caregivers mounting a four-fold increase from baseline compared to 59% of 
controls (Glaser et al., 1998). Only responders were followed the subsequent three and six 
months, which revealed that former relative to current caregivers showed a less robust T cell 
response. The data from each study reveals that caregiving stress (regardless of current or 
former status) impairs humoral and cellular immune response to influenza vaccination 
relative to age, sex, socioeconomic status, and health-matched controls (Glaser et al., 1998). 
Furthermore, it shows that the stress of care-giving has persistent immune consequences 
that do not cease upon alleviation of care-giving responsibility. The same group later 
examined whether mild depressive symptoms were associated with IL-6 response to flu 
vaccination in healthy elderly individuals (Glaser et al., 2003). They found a significant time 
X depressive symptoms interaction (which persisted even when health factors impacting IL-
6 were accounted for), with elevated IL-6 at two weeks associated with higher depressive 
symptoms (Glaser et al., 2003). Although those with prior vaccination history did not differ 
from those without, this may have been an artifact of different strain compositions across 
years. As it was not specified whether assays were conducted for each strain, this may have 
accounted for a lack of Ab effects. Indeed, Vedhara and colleagues (1999) found that 
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caregivers exposed to influenza were less likely to show an adequate Ab response to 
vaccination, and had less Ab production to the Nanchang strain, but not to other strains. This 
impaired Ab response was also inversely correlated to cortisol. Thus, it appears that HPA 
activation mediates the stress-immune suppression relationship in elderly caregivers of 
dementia patients in a strain-specific manner (Vedhara et al., 1999). Miller and collaborators 
(2004) have found similar strain-specific effects in a young sample. High stress groups 
(compared to low and medium) showed a blunted Ab response only to the New Caledonia 
strain (Miller et al., 2004). It is clear from these studies that exogenous (non-inoculation 
based) stress has a profound interactive effect with NA on immunological response to 
inoculation. Hence, the present study will examine whether presence of stressors will 
moderate the relationship between NA and Ab response. Stressors will be examined across 
two dimensions: psychogenic (i.e., stressful life events) and systemic (i.e., presence of a 
chronic disease state).  
H3: Existence of stressors (psychogenic and/or systemic) may act as 
moderators in the relationship between State NA and Ab response. 
This approach is particularly relevant to the population under study, as the likelihood of 
both stressful life events (i.e., death of a loved one) and chronic illness increases in an elderly 
sample. Additionally, presence of a disease state may drive down the immune response due 
to constant physiological demands reducing functional capacity. As such, it is a necessary 
piece of the PNI puzzle to identify whether these stressors influence the relationship 
between NA and immune response. As an extension of this hypothesis, and a further 
clarification of how individuals with NA somatize, the impact of NA and psychological and 
systemic stress will be investigated in relation to systemic symptom reports. Systemic 
symptoms will be restricted to those related to immune activation subsequent to inoculation 
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to control for possible confounds between symptoms associated with chronic disease states, 
though some overlap may inevitably occur. 
H3a: Individuals with high NA and high stress will show enhanced systemic 
symptom reporting. 
Although superficially contrary to the common sense framework, which asserts that 
individuals experienced with somatic activation accurately assess somatic states, we speculate 
that this heightened systemic symptom reporting will be unrelated to Ab response. Given 
the hypothesized associations between high NA, stress and chronic disease, and Ab response, 
it could be expected that those high in NA with comorbid chronic disease states and low Ab 
response would actually be more sensitive to somatic changes. The exaggerated NA would 
direct attention to the soma, with chronic illness experience informing somatic cues of 
physiological activation in spite of reduced Ab response. Also consistent with the common 
sense framework, individuals who display a robust Ab response will report higher levels of 
systemic symptoms, hence hypothesis 3b. 
H3b: Systemic symptom reporting alone will be unrelated to Ab response. 
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Positive Affect, Health, and Immunity 
 While the detrimental effect of negative affect on health has been the prevailing 
concentration in investigating the relationship between emotion and health, a paradigm shift 
seems to be emerging that changes focus from pathology to prophylaxis. Seligman's 
pioneering approach to human mental health, broadly termed Positive Psychology, examines 
how an optimistic, happy emotional state contributes to human health. Positive Affect, PA, 
is not merely a diminished negative affectivity but instead represents a distinct construct 
(Watson, 1988a). Still in its infancy, this perspective has been largely neglected in PNI until 
quite recently. It is feasible that PA may promote better health via a number of potentially 
interacting pathways: more positive health practices (Watson, 1988b), enhanced regulation of 
emotional circuits influencing immunity (Stone et al., 1987), more adaptive stress coping 
style (Fredrickson, 2001). Higher PA has been shown to predict fewer negative health 
symptoms in a healthy collegiate sample, even when cigarette smoking, alcohol consumption, 
and NA were all controlled. Also, health worsened for those low in PA, but slightly 
improved for those with high PA (Pettit et al., 2001). Conclusions must be made with 
caution; however, as the likelihood of symptomatology in this group would be low, especially 
as no controlled immune challenge was given. Cohen and collaborators have begun to 
investigate the relationship between PA and immune challenge. Using rhinovirus challenge, 
they found that PA was inversely associated, in a dose-dependent manner, with rate of 
clinical cold, whether quantified as objective or subjective illness (Cohen et al., 2003b). 
Although PA was significantly associated with better health practices (i.e., sleep quality, diet, 
and exercise) and endocrine measures (i.e., decreased noradrenaline, adrenaline, and cortisol), 
none of these acted as mediators, suggesting PA has a direct influence on cold illness (Cohen 
et al., 2003b). Negative affect showed no relationships with PA, cold susceptibility or 
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verifiable illness, though individuals high in NA did show increased vague systemic symptom 
reports (Cohen et al., 2003b). 
H4: Positive affect, PA, will be associated with enhanced Ab response to 
influenza vaccination.   
 
The following hypotheses summarize the predictions of the current investigation: 
H1: Trait negative affect, NA, will have no impact on Ab response to 
influenza inoculation. 
H2: State changes in NA will associate with differential Ab response to 
influenza vaccination. High baseline State NA will associate with decreased 
Ab response. This attenuated Ab response will then lead to reduced NA at 
follow-up. 
H2a: The relationship between State NA and Ab response will be most 
evident the first year of strain exposure, but will remain to a lesser 
degree over the long-term. 
H3: Existence of stressors (psychogenic and/or systemic) may act as 
moderators in the relationship between NA and Ab response. 
H3a: Individuals with high NA and high stress will show enhanced 
systemic symptom reporting. 
H3b: Systemic symptom reporting alone will be unrelated to Ab 
response. 
H4: Positive affect, PA, will be associated with enhanced Ab response to 
influenza vaccination.   
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 The present study adds substantially to the existing literature by following 
immunological, health, affective, and experiential information in healthy, elderly individuals 
throughout the span of five years. Further, instead of focusing on a sole explanatory factor 
in the relationship between mind and health, it provides a multifactorial perspective on the 
dynamic interplay amongst affective, experiential, and physiological variables. This approach 
is more consistent with how an organism exists in the natural world, thus making it a more 
pragmatic model than standard reductionist approaches. The current series of studies also 
provides a new perspective on the relationship between affect and health in exploring the 
impact of positive affect on immunological response to influenza vaccination. It also has 
many potential intervention applications. For example, through enhancing certain affective 
characteristics while reducing others, and understanding the conditions under which the 
tendencies most robustly operate, vaccination outcomes can be enhanced. Moreover, 
knowing the populations which would benefit the most from such interventions can lead to 
enhanced targeting of strategies. To examine the dynamic interplay between affective 
tendencies (both negative and positive), stress, and physiological response to immune 
challenge enables a much broader and more ecologically relevant perspective on the complex 
relationship between emotion and human health.  
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METHODS 
 
1. Study I: A longitudinal (five-year) investigation of the relationships amongst 
negative affect, chronic illness, stress, systemic symptom reporting, and antibody 
response to influenza vaccination in the elderly. 
      
1.1 Materials and Methods 
1.1.1 Participants. The participants of this study were residents of a retirement community 
recruited from a larger-scale (N=851) nine-year longitudinal study of physical health and 
psychosocial well-being (Rutgers Aging and Health Study, RAH). Of the original participants, 
152 participants (97 female, 55 male; age range: 59-90 years, M=72.49, SD=6.32) from two 
separate immunological cohorts (1991, N=41, 27%; 1992, N=111, 73%) met medical 
exclusionary criteria (refer to Appendix A) and completed all three annual assessments 
spanning the years 1992, 1993, and 1996. Annual assessments consisted of both in-person 
(for baseline inoculation and two-week post-inoculation sessions) and telephone (for 
summer assessment six months prior to inoculation) interviews reporting information about 
lifetime medical history, recent and current illness episodes, health care utilization, life events, 
social networks, and emotional status. 
1.1.2 Psychometric Assessments. In the summer months preceding each year of the study, 
participants completed a comprehensive psychometric evaluation. Along with demographic, 
overall health status, psychosocial, and stress information, the evaluation consisted of an 
interview assessing the cognitive, mood, and somatic components of depression and anxiety.  
 Anxiety and Depression. Items from each of the Depression and Anxiety subscales of 
the Beck Cognition Checklist (Beck et al., 1987) measured the cognitive components of 
depression and anxiety, respectively. Participants were asked to respond on a Likert scale (1 
to 5, with 1= never to 5= always) to items such as "When you're with a friend how often do 
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you think 'I don't deserve to be loved'?" and "How often do you think 'I'm going to have an 
accident'?" for depressed and anxious thoughts, respectively. The somatic aspects of 
depression and anxiety were assessed by the Centers for Epidemiological Studies, 
Depression subscale (CES-D, Radloff 1977) and Krantz anxiety inventory (Contrada, Hill, 
Krantz, Durel & Wright, 1986), respectively. For the CES-D, participants rated on a Likert 
scale ranging from 1 to 4 (1=none of the time or rarely, to 4= most or all of the time) how 
often in the past two weeks they had experienced a host of symptoms (i.e., restless sleep, 
poor appetite). Somatic anxiety was assessed with participants rating frequency (on a Likert 
scale of 1=never, to 5=always) with which they experienced somatic sensations associated 
with anxiety, such as increased heart beat or jitteriness. Questions were phrased as "When 
anxious or nervous, how often do you feel _____?" Mood items were also queried using a 
Likert scale (1=never, to 5=always) with mood adjectives inserted in the following sentence 
structure: "How _______ are you usually?" for trait assessment, and "How _______ were 
you in the past 24 hours?" for state assessment. For state inquiry, items were phrased using 
"the past 24 hours" to decrease the likelihood of biased responses. 
 Principle components factor analysis was used to extract one component 
representing depression and one representing anxiety. Upon extraction of the factor score, 
separation into tertiles yielded the following groups for depression and anxiety: high, 
moderate, and low.  
   
 Symptomatology. To examine whether systemic symptom reporting consistent with 
immunological activation mediated the relationship between NA and Ab response, a 
systemic symptom score was created. Only symptoms that could be attributed to vaccine-
related immunological activation were utilized (e.g., headache, throat symptoms, muscle 
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aches, fatigue, general sickness, and fever). Participants rated not only presence of symptoms, 
but also degree of symptomatology on a Likert scale ranging from 0 to 6, indicating 
complete lack of symptoms to severe and chronic symptoms, respectively. Items were 
summed to give a systemic symptom score for each time point.   
 Stress. Number of stressful life events (including only those of maximal impact, i.e., 
death and martial discord/divorce) were summed as an objective measure of stress exposure 
to yield a psychological stress score.  Also, since it was not only valuable to examine the role 
of systemic stress, but also of immunological significance to consider the impact of chronic 
illness, presence of chronic disease states was quantified and entered as an independent 
variable. A dichotomous variable specifying whether participants had ever (during the entire 
span of the study) experienced chronic illness or not was created.   
1.1.3 Immunological Assays. Phlebotomists drew 27-ml venous blood samples from each 
participant immediately before inoculation on the day of inoculation, and again at two weeks 
post-inoculation to assess IgG response to inoculation. All inoculations were administered 
by a trained nurse. A portion of each blood sample was placed into a seven ml preservative-
free vacuum tube. The whole blood samples were centrifuged, after clotting at ambient 
temperature, and the serum portion remove and aliqouted into to samples which were then 
frozen and stored at -70 degrees C. Upon study completion, one set of aliquots was shipped 
on dry ice to the University of Wisconsin, Geriatric Research Laboratory, Milwaukee Clinical 
Campus. Hemagglutinin Inhibition Assay (HAIA) was used to measure IgG antibodies to 
each of the influenza, FLU, strains (provided by Wyeth, Marietta, PA) (see Table 1 for list of 
viral components in the annual trivalent inoculation), and was performed according to 
Centers for Disease Control specifications.  
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 Chicken red blood cells (cRBCs) were used in the assay. Sera were treated with 0.1 
milliliter, ml, of 0.1% trypsin and incubated in a 56 degree C water bath for 30 minutes. 
After ambient cooling for 5-10 minutes, 0.5 ml KIO4 was added and another 30 minute 
incubation occurred, followed by addition of 0.1 ml glycerol (in 4% NaCl) and overnight 
storage at 4 degrees C in 0.2 ml 0.01 M PBS. In a 96-well V-bottom microtiter plate, 25 
microliter (μl) of PBS were added to all test wells and 50 μl of sample serum were added to 
the first wells. All antibody titers were run with serially diluted samples from 1:10 to 1:10,240, 
and calculated based upon dilution of the antigen. Twenty-five μl of FLU antigen (diluted to 
the concentration previously determined by antigen titration) were added to each test well. 
Gentle tapping mixed the plates, which were incubated at ambient temperature for 30 
minutes. After 50 μl of 0.5% cRBCs were added to test and control wells, plates were again 
mixed and incubated for 30 minutes. Upon complete settling of all cRBCs to the bottom of 
wells, plates were tilted at a 45 degree angle and the wells read for agglutination/inhibition of 
agglutination or "streaming." Titers were reported as the reciprocal of the highest sample 
dilution showing complete agglutination of the antigen according to the following formula: 
Z * Do/8 = Dt (Z=reciprocal of highest dilution showing complete agglutination; Do= 
original dilution of antigen to begin titration; Dt= dilution factor to give HAU per unit 
volume [25 µl]). To ensure accuracy, a cRBC control serum and a back titration were 
included on each plate. The laboratories performing immunological assays were blind to the 
participants' name, age, sex, and condition.  
 
1.2 Procedure 
Initial immunological participation occurred in two waves (1991 and 1992), using an AB-BA 
design in which participants were randomly assigned to either placebo-inoculation or 
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inoculation-placebo groups. Each of the three years 1992, 1993, and 1996, participants 
underwent a series of interviews followed by influenza vaccination and subsequent 
immunological assays (while inoculation did occur in 1994 and 1995, immunological assays 
were not conducted and hence these years were excluded). All participant visits were 
conducted between 0800 and 1200. Participants were interviewed in person at a centrally-
located meeting room in the retirement community in the summer months preceding 
immunological assays to collect initial affective measures, overall health assessment, and 
demographic and psychological information. Six months later, at the end of October 
through early November, inoculations, immunological assays and follow-up interviews were 
conducted.  
 At the first winter appointment, written consent was obtained and participants were 
administered a baseline interview, blood pressure and temperature readings were taken, 
blood was drawn, and inoculation with either placebo (saline) or active inoculants (trivalent 
FLU, tetanus toxoid [TET], and keyhole limpet hemocyanin [KLH]) was delivered. The 
TET and FLU inoculations were delivered intramuscularly (one in the deltoid of each arm), 
and the KLH was delivered subcutaneously in the deltoid of the non-dominant arm (the 
placebo, 0.5 ml each of saline, condition likewise consisted of two intramuscular and one 
subcutaneous administration). (Although TET and KLH were also administered, only FLU 
response will be discussed herein.) Two weeks later participants returned for the same 
procedure, receiving the alternate inoculation at this time. Venous blood was drawn at the 
first visit and two weeks and four weeks (only for those participants who received placebo at 
the first visit) later to assess immunological response to inoculation. As there was no 
response to placebo, only inoculation immunological profiles will be discussed. The double-
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blind, placebo-controlled study was approved by the Human Subjects Internal Review Board 
at Rutgers University and the University of Medicine and Dentistry of New Jersey. 
 
2. Study II: A longitudinal (five-year) investigation of the relationship between 
positive affect and antibody response to influenza vaccination in the elderly. 
      
2.1 Materials and Methods 
2.1.1 Participants.  The same study participants detailed in Section 1.1.1 were used to assess 
the relationship between positive affect and Ab response to influenza vaccination.  
2.1.2 Psychometric Assessments. Positive affect, PA, was quantified along two dimensions: 
optimism and mood. Optimism was measured via the Mehrabian Optimism-Pessimism scale 
(Mehrabian, 2000). Mood items were drawn from the same scale as discussed in Section 
1.1.2, but only included items relating to pleasant (happy, cheerful, content, pleased) and 
energetic affect (enthusiastic). Both measures were administered in the summer months 
preceding inoculation. Scores for each year were summed yielding continuous variables, 
from which the two PA dimensions were categorized into three groups each (Low, Moderate, 
and High) from tertiles.    
2.1.3 Hemagglutinin Inhibition Assay. Refer to Section 1.1.3 for details of the HAIA. 
 
2.2 Procedure 
The procedure was identical to that of Section 1.2. 
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RESULTS 
Statistical Analyses and Data Cleaning. Antibody titers were log (base-10) transformed to 
better approximate normal distributions, and quantified as percentage change at two weeks 
from baseline. Furthermore, vaccine response is conventionally recognized as 4-fold 
antibody increase, and as such individuals whose influenza titers increased by this amount or 
more were considered to be "responders." While it was plausible that the 1991 and 1992 
cohorts would show different baseline levels of Ab due to prior exposure, analyses did not 
reveal a group difference in baseline Ab titer (p>0.15). As such, all Ab results are reported 
pooled across cohorts. Within subjects regressions yielding slopes were performed to 
examine changes in affect and Ab production. Longitudinal hypotheses were tested using 
repeated-measures general linear models and multiple linear regression models, allowing for 
incorporation of the within-subjects repeated antibody response. For regression, standard 
controls, including sex, age, and baseline Ab levels, were entered as the first step, followed 
by appropriate psychological variables, and a third step was included when interactions were 
tested. Affect groups (High, Moderate, or Low) were the between-subjects independent 
variables, and the dependent measures of antibody response were repeated across time (the 
years 1992, 1993, and 1996). Given the prevalence of influenza strain-specific effects, 
separate regressions were carried out for each of the strains.  
 To further clarify the relationship between NA and Ab response, tests were also 
conducted to determine whether psychogenic and/or systemic stress, as well as systemic 
symptomatology, acted as moderators/mediators. Bivariate data were analyzed with χ2. All 
data was analyzed using SPSS 15.0 for Windows, with α level set at 0.05 to indicate statistical 
significance. Greenhouse-Geisser corrections were applied when the data did not meet 
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assumptions of sphericity, and Wilks Lambda was used when data did not meet assumptions 
of equality of covariance. 
 
1. Hypothesis I: Trait negative affect (NA), measured in the summer months 
preceding inoculation, will have no impact on Ab response to influenza vaccination. 
 As Trait affect represents a stable personality attribute, to which the organisms' 
physiology adapts over a lifetime, there are no expected alterations of Ab response (either 
cross-sectionally or longitudinally) according to Trait NA category. However, in as much as 
high Trait NA may represent an enhanced predisposition toward stress reactivity, the 
psychological and physiological stress of inoculation may result in short-term (only cross-
sectional) associations with Ab response. 
 
1.1 Associations between Negative Affect and Ab Response to Influenza Inoculation 
 Separate analyses were run to assess whether the two components of NA, depression 
and anxiety, were associated with Ab response to the individual strains. Both cross-sectional 
and longitudinal assessments were made.   
 
1.1.1 Cross-sectional Associations between Trait NA and Ab Response  
 Preliminary correlations showed no association between Trait NA and Ab response 
the first or last years of the study, although Trait depressed and anxious NA were 
significantly positively correlated (see Tables 2 and 3). However, in 1993, Trait anxious NA 
did positively correlate with Ab change to Panama, though this correlation was modest (see 
Table 4). Across all years, Ab responses to each of the strains were significantly positively 
correlated with one another (see Tables 2, 3, and 4).  
35 
 
 Univariate ANOVA was used to clarify the relationship between Trait NA and Ab 
response to Panama in 1993. No significant effects were observed of Trait anxious NA group 
on Ab response to Panama, either in multivariate, F(2,144)=1.038, p=0.357, or univariate 
tests, F(2,144)=1.663, p=0.193, indicating this was a spurious effect. As hypothesized, Trait 
NA was unrelated to cross-sectional examinations of Ab response. 
 
1.1.2 Longitudinal Associations between Trait NA and Ab Response 
 To examine whether trait NA bears a relationship with long-term Ab response, first 
it was important to ensure that it represents a stable attribute. Repeated measures ANOVA 
confirmed stability across years for Trait depressed NA, F(2,150)=0.059, p=0.942, and Trait 
anxious NA, F(2,150)=0.176, p=0.839.  Trait NA had no long-term effects on Ab response 
to Beijing89, Beijing92, Taiwan or, Texas strains (p>0.05). However, there were significant 
univariate effects for Trait anxiety and Panama response, F(2,144)=3.157, p=0.046. 
Individuals with Low Trait anxiety showed a consistent Ab response to Panama across all 
years, while those with High Trait Anxiety showed a steady decline, and Moderate Trait 
Anxiety showed a steady response the first two years with a subsequent decline in 1996 
similar to those with High anxiety (see Figure 3). 
 Given this unexpected finding, further examinations of potential confounding 
extraneous factors accounting for this long-term relationship between Trait anxious affect 
and Panama response were sought. As we speculate that baseline State NA is likely to bear a 
relationship with Ab changes, correlations between Trait anxious affect, baseline state 
anxious affect, and Panama response were investigated. Although Trait anxiety and state 
anxiety were indeed significantly positively correlated (p<0.001), changes in State anxiety 
added as a covariate did not alter results of the repeated measures analysis, indicating this 
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factor was not attributable to the relationship between Trait anxiety and Panama response. 
Similarly, presence of chronic illness and psychological stress history did not act as covariates. 
Hence, it appears that Trait anxious affect does exert a long-term impact on Ab response 
profile, if only to the Panama strain. 
 
1.2 Summary 
 As hypothesized, Trait NA showed no cross-sectional relationships with Ab 
response. Likewise, there were no associations between Trait NA and long-term Ab 
response to Beijing89, Beijing92, Taiwan, or Texas. However, a relationship between Trait NA 
and long-term Ab response to Panama did emerge. Moderate Trait anxiety showed enhanced 
Ab response to Panama the first year, followed by a steady decline subsequent years, while 
Low Trait anxiety showed a low, stable response across years (High levels of Trait anxiety 
did not vary significantly from the other two groups). Although potential confounding 
factors were investigated, the relationship remained, indicating that Trait anxiety exerts a 
long-term effect on response to Panama. 
 
2. Hypothesis 2: State changes (from baseline to two weeks post-inoculation) in NA 
will associate with differential Ab response to influenza inoculation, with High 
baseline State NA associating with decreased Ab response. Decreased Ab response 
will then predict decreases in State NA at follow-up. 
 Unlike Trait NA, State NA should more accurately reflect stress reactivity bound to a 
contextual event (i.e., inoculation), and as such should associate with alterations in Ab 
response to inoculation. The psychological stress of inoculation may enhance NA, 
particularly anxious affect, at baseline and the noradrenergic and HPA effects of this 
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heightened stressful state will associate with decreased Ab response. The decreased Ab 
response in individuals with high NA will then result in an alleviation of NA at follow-up 
(the 2-week time point) in those with high baseline NA. Thus, we expect to see declines in 
State NA in individuals with poor Ab response. 
 
2.1.1 Cross-sectional Associations between Changes in State NA and Ab response 
  Two separate models will be investigated herein. Model I seeks to explain degree of 
Ab response (slope from baseline to 2-weeks post-inoculation) dependent upon baseline NA. 
Model II seeks to identify how State NA varies according to magnitude of Ab response. 
Hence, two separate regression models will be conducted to examine these distinct efferent 
and afferent pathways, respectively, linking affect and immunity.  
 
2.1.1a Model I: Impact of Baseline State NA on Ab Response 
 Multiple linear regression was used to investigate whether baseline State NA impacts 
Ab response at two weeks post-inoculation. Age and baseline Ab titer were entered as the 
first step, followed by baseline NA (depression and anxiety). Change in Ab response over 
two weeks (slope) was used as the independent measure. As stated above, separate 
regressions were implemented for each strain. In 1992, there was only a significant effect of 
baseline level of depression on Ab response to Panama (ΔR2=0.029), F(4,147)=7.865, 
p<0.001. However, in 1993 depression had no effect but baseline anxiety showed significant 
associations with Ab response to Beijing92 (ΔR2=0.022; F(4,147)=15.962, p<0.001), Taiwan 
(ΔR2=0.024; F(4,147)=12.878, p<0.001), and Texas (ΔR2=0.024; F(4,147)=8.734, p<0.001). 
Baseline anxiety in conjunction with depression acted as a predictor for Taiwan (ΔR2=0.030), 
F(4,147)=2.578, p<0.040, response during the last year of the study. Contrary to 
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expectations, low baseline depression and anxiety predicted poor Ab response. High baseline 
anxiety only equated with poorer Ab response to Taiwan in 1996, as hypothesized.  
 
2.1.1b Model II: Impact of Ab Response on NA 
 In this model, we sought to understand the impact of immune activation on follow-
up State NA, and as such multiple linear regression was employed. Age was again entered as 
the first step, excluding baseline Ab titer, and including instead baseline NA. The second 
step included both Ab titer at week 2 and Ab slope. The independent variable was change in 
NA (depression and anxiety, separately). As before, separate regressions were carried out for 
each strain. During the first year of the study, elevated Ab titer at two weeks predicted 
decreased anxiety for Beijing92 (ΔR2=0.042; F(4,147)=11.948, p<0.001), Taiwan (ΔR2=0.019; 
F(4,147)=8.988, p<0.001), and Texas (ΔR2=0.020; F(4,147)=10.587, p<0.001). Interestingly, 
the effects of Taiwan titer and change dissociated from one another, with decreases in 
response (slope) predicting decreases in anxiety. Enhanced Taiwan titer also predicted 
decreases in depression, and there was a trend for Panama titer to predict decreases in 
depression, as well. In 1993, there were no observable associations between Ab 
responsiveness and changes in NA, but associations again emerged in 1996. Beijing89 change 
acted as a negative predictor of depression change (ΔR2=0.039), F(4,147)=10.163, p<0.001, 
while Beijing92 titer was a positive predictor of depression change (ΔR2=0.030), 
F(4,147)=11.199, p<0.001.  
 Contrary to hypotheses, elevated Ab titer at two weeks post-inoculation predicted 
decreased state anxiety and depression, particularly the first year of the study. All 
associations disappeared the subsequent year, but in 1996 changes in Ab response then 
predicted alterations in state depression in a similar manner as in 1992. It is also important to 
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note that the two measures of Ab response (slope and titer value) had paradoxical 
associations with NA, illuminating the importance of considering how this dependent 
measure is quantified.  
 
2.1.2 Longitudinal Associations between State NA and Ab Response 
  As the initial stressful nature of the inoculations may wane with repeated experience, 
it is thus important to examine how affective states and Ab response covary across time. No 
correlations were observed between change in baseline NA and Ab response slope across 
years. However, there were significant negative correlations between change in both 
measures of NA at 2 weeks and Taiwan Ab slope (see Table 5), indicating that declines in 
state NA associate with enhanced long-term Ab response to Taiwan. Repeated measures 
ANOVA was used to more fully examine this relationship. For this purpose, individuals 
were grouped into one of three categories (No change, Decrease, or Increase), depending on 
the direction of State NA slope they exhibited across years. Repeated measures ANOVA 
confirmed a lack of effects for changes in baseline state NA on long-term Ab responsiveness 
(p>0.20). Follow-up state NA also had no relationship with Ab response to Beijing89 (Dep: 
F(2,144)=1.966, p=0.144; Anx: F(2,144)=0.132, p=0.876) or Texas (Dep: F(2,144)=1.862, 
p=0.159; Anx: F(2,144)=0.391, p=0.677) strains.  
 However, interesting multivariate and univariate effects, and interactions were 
discerned for Beijing92, Panama, and Taiwan. Significant multivariate year (F(2,143)=29.296, 
p<0.001), year*Dep (F(4,286)=5.251, p<0.001) and year*Dep*Anx (F(6,286)=5.355, p<0.001) 
effects were found for Beijing92 Ab response. The Depression change categories showed 
distinct Ab response profiles across years (see Figure 4). Individuals displaying no change 
(N/C) in follow-up Depression showed a very robust Ab response to Beijing92 in 1992 
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followed by diminished but stable response the following years. Those whose follow-up 
Depression increased (Inc Dep) over the study showed blunted Ab response the first year, 
but then a peak the following year, with a return to initial levels in 1996. Stable long-term Ab 
response was associated with decreasing Depression (Dec Dep). While there were no 
significant multivariate effects of follow-up Anxiety, F(4,286)=0.400, p=0.808, there were 
significant there were significant univariate effects for follow-up Anxiety category, 
F(2,144)=3.351, p=0.038. Individuals with decreasing levels of follow-up Anxiety (Dec Anx) 
had significantly greater Ab response to Beijing92 than those with increasing follow-up 
Anxiety (Inc Anx) (see Figure 5). The picture becomes more complex when the interaction 
between year, Depression, and Anxiety is observed (see Figure 6). It is apparent that lack of 
State NA change is associated with long-term Ab response profiles distinct from other NA 
combinations, in that individuals with no change in one domain of NA combined with 
deceases in the other show the most robust Ab response the first year followed by a 
dramatic decline subsequent years, while all other affective permutations demonstrate a 
similar pattern of stability or slight increase after the first year of inoculation. This interactive 
effect was also observed for response to Panama, F(6,286)=2.146, p=0.048, though to a 
much lesser degree and only for the decreased Depression-N/C Anxiety group (see Figure 7). 
Follow-up Depression category had significant univariate effects on Panama response, 
F(2,144)=3.410, p=0.036, with decreased Depression showing a more robust Ab response 
compared to increased Depression (see Figure 8). As with Panama response, although the 
interaction between year, Depression, and Anxiety was the only significant multivariate 
effect for Taiwan response, F(6,286)=2.404, p=0.028, both follow-up Anxiety and 
Depression showed univariate effects (F(2,144)=3.685, p=0.027 and F(2,144)=2.898, 
p=0.058, respectively). While stable follow-up Anxiety was associated with enhanced Ab 
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response relative to increased Anxiety (see Figure 9), decreases in Depression showed 
enhanced Ab response compared to those showing increases (see Figure 10).  
 
2.2 Summary 
 Cross-sectionally, two models were proposed to examine the relationship between 
state NA and Ab response to inoculation. Model I examined how baseline State NA would 
act efferently to predict Ab response two weeks post-immunization, while Model II 
investigated the afferent impact of Ab response on changes in state affect two weeks post-
inoculation. Unexpectedly, high baseline levels of NA were associated with enhanced Ab 
response in a year- and strain-dependent fashion. The only finding which supported the 
hypothesis was that high baseline State anxiety equated with poorer Ab response to Taiwan 
in 1996. While significant associations were observed for Model I, most of the models 
accounted for less than 50% of the variability in the Ab response (the most robust model 
was observed for Beijing92 response in 1993, accounting for 55% of the variability in Ab 
response), hence other factors are exerting an influence on Ab response either independently 
of or in conjunction with NA, which will be investigated in Hypothesis 3. Again with Model 
II the anticipated associations were, for the most part, not observed. While it was expected 
that lower Ab titer/less robust response (slope) would predict decreases in NA, the opposite 
relationship emerged. Strain- and year-specific effects again emerged, and furthermore the 
two means of quantifying Ab response dissociated from one another in their impact on 
changes in state NA. While slope exhibited the predicted direction of effects (positive 
associations), it was also a less consistent predictor than titer, which showed the unexpected 
associations with State NA. Also, since the most consistent effects were observed the first 
year, it is likely that the novelty of initial exposure produced the most robust relationships 
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between Ab response and state NA. As with Model I, the factors in Model II accounted for 
maximally 50% variability in NA change, and as such, this indicates that other factors 
influenced alterations in state NA during the time of immune activation. Hypothesis 3 will 
address some of these potential mediating factors.  
 Another aspect of Hypothesis 2 investigated how changes in state NA covary with 
Ab response over the course of the entire study, not just within each year. As such, 
longitudinal tests were conducted relating long-term state NA slope (decrease, increase, or 
no change across years) with Ab response in a repeated measures design. While changes in 
baseline state NA had no effect on Ab response to any of the strains, contrary to 
expectations, long-term changes in follow-up (two weeks post-immunization) NA were 
observed in relation with response to Beijing92, Panama, and Taiwan. A multitude of effects 
(multivariate, univariate, and interaction) were observed for Ab response to Beijing92. 
Decreasing levels of follow-up Anxiety associated with much greater Ab response to 
Beijing92 than did those with increasing levels of Anxiety. Depression change category 
interacted with year, evidencing distinct immunological profiles. Very robust Ab response to 
Beijing92 the first year of the study, followed by a dramatic decrease in subsequent years was 
associated with no change in follow-up Depression. Stable Ab response across years 
coincided with decreases in follow-up Depression; while increases in follow-up Depression 
were associated with low Ab response the first year, with a peak the following year and 
returning to low levels the last year of the study. Interactions between changes in Depression, 
Anxiety, and year were also observed, with no change in one NA dimension combining with 
decreases in the other associating with robust Ab response the first year followed by 
decreases subsequent years. This interaction was observed across Beijing92, Panama, and 
Taiwan strains. However, for Panama and Taiwan this effect was observed only for those with 
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decreases in Depression and no change in Anxiety, which appeared to be mainly driven by 
Depression category for the former and Anxiety category for the latter.  
 Contrary to the hypothesis that baseline alterations in NA would be the best 
predictor of Ab response, it was follow-up NA that showed the most consistent 
relationships with Ab response. Establishing directionality is challenging, as variations in Ab 
response may actually be the driving force for long-term changes state NA. In this case, the 
most robust Ab response associates with either no change or decreases in NA in conjunction 
with subsequent decreases in robustness of Ab response. This may be explained in that it 
would be expected that Ab response would be the most pronounced the first year of 
antigenic challenge, and as such relate to higher levels of NA, which would decline as 
immune responsiveness declines. The longitudinal results help reconcile some of the 
inconsistencies found in cross-sectional investigations, as there is a dynamic relationship 
between changes in state NA, Ab strain, and time that is masked when examining a single 
point in time.  
 
Hypothesis 3: Existence of stressors (psychogenic and/or systemic) may act as 
moderators in the relationship between NA and Ab response. 
 The presence of a chronic disease state may inform how an individual reacts to a 
systemic stressor, particularly one of a known immunological origin. It is predicted that 
individuals with high NA and a chronic disease will be more reactive to stressors, and hence 
show the greatest downregulation of Ab response. Additionally, presence of the disease state 
itself may drive down the immune response due to constant physiological demands reducing 
functional capacity. Conversely, experience with chronic disease may protect an individual 
from the psychologically stressful nature of immunological activation due to extensive prior 
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experience with somatic symptomatology, thereby protecting against decreased Ab 
production.  
 
3.1 Tests of Psychogenic and Systemic Stress as Moderators 
 To examine whether psychogenic and systemic stress operated as pathways between 
NA and Ab response, moderator tests were executed. As such, it was expected that 
psychogenic and systemic stress would correlate with NA and account for variations in Ab 
response. Furthermore, when the moderators are controlled for, associations between NA 
and Ab response should be substantially reduced (Baron and Kenny, 1986). 
 
3.1.1 Psychogenic Stress as Moderator 
  No significant correlations existed between stressful life events and NA (see Tables 6 
through 8), indicating psychogenic stress does not act a moderator for NA and Ab response. 
 
3.1.2 Systemic Stress as Moderator 
  Positive correlations between existence of chronic illness in 1992 and both baseline 
and follow-up State anxiety, and follow-up depression were indeed found, indicating that 
systemic stress potentially acted as a moderator for NA and Ab response (see Table 9). 
However, this relationship did not persist in 1993 or 1996, with all significant correlations 
between chronic disease and NA disappearing (see Table 10 and Table 11, respectively). This 
provides evidence that any moderating effects of systemic stress on the relationship between 
NA and Ab response are transient, at best.  
 Since there were significant correlations between systemic stress and three measures 
of State NA (with a trend also in baseline State depression) in 1992, chronic illness was 
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included in regression models (Model I) to determine whether it acted as a moderator or 
even as an independent predictor of Ab response in 1992. Systemic stress acted as neither a 
moderator nor an independent factor in the relationship with Ab response, as it did not 
account for any further variability in the dependent measure nor did it change the degree to 
which baseline depression influenced Ab response to Panama in 1992.  
 
Hypothesis 3a: Individuals with high NA and high stress will show enhanced 
systemic symptom (those symptoms associated with immune activation) reporting. 
This enhanced systemic symptom reporting will act as a covariate in the 
relationships between Ab response and changes in NA (Model II). 
  
 There were significant positive correlations between systemic stress and systemic 
symptom reporting, and systemic symptom reporting and three out of four measures of 
changes in State NA the first year of the study (see Table 12). The following year, significant 
correlations remained between systemic stress and the NA measures, however, the 
correlation with systemic symptom reporting ceased to exist (see Table 13). The correlation 
between systemic symptoms and systemic stress re-emerged in 1996, and systemic symptoms 
also positively correlated with stress history and 2-week NA (see Table 14). Across all years, 
stress history did not correlate with NA or systemic stress, making psychogenic stress an 
unlikely moderator.  
 Again, to examine whether systemic symptom reporting acted as a mediator, this 
measure was entered into regressions (Model II) to identify whether it reduced the 
association between Ab response and follow-up NA. Systemic symptom reporting did not 
substantially reduce the association between Ab response and follow-up NA in 1992, though 
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it did act as an independent factor to strengthen the model. Hence, although not a mediator, 
systemic symptoms acted as a facilitator in the relationship between Ab response and 
changes in NA. However, in the final year of the study, systemic symptom reporting did 
reduce the associations between Beijing89 response and depression (from ΔR2 of 0.039 to 
0.021) and Beijing92 response and depression (from ΔR2 of 0.030 to 0.011). Thus, systemic 
symptom reporting likely mediated the associations between Ab response and change in 
depression in 1996.  
 
Hypothesis 3b: Systemic symptom reporting alone will be unrelated to Ab response. 
 Although superficially contrary to the common sense framework, which asserts that 
individuals experienced with somatic activation accurately assess somatic states, we speculate 
that this heightened systemic symptom reporting will be unrelated to Ab response. Given 
the associations between high NA, stress, and Ab response it is expected that those high in 
NA with comorbid chronic disease states and low Ab response will actually be more 
sensitive to somatic changes. Also consistent with the common sense framework, individuals 
who display a robust Ab response will report higher levels of systemic symptoms. 
 
 As hypothesized, preliminary correlations revealed no significant associations 
between systemic symptom reporting and Ab response across all years (see Tables 15 
through 17). To ensure that non-linear relationships between systemic symptom reports and 
Ab response were not being overlooked, individuals were categorized as being Non-
reporters, Low reporters or High reporters and ANOVA was used to test for significant 
effects. There were no significant relationships between systemic symptom reporting 
frequency and Ab response in 1993 (p>0.15) and 1996 (p>0.20). In 1992, only Beijing89 
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response barely associated with systemic symptom report status, F(2,148)=3.063, p=0.050. 
Individuals who were Low symptom reporters showed enhanced Ab response relative to 
Non-reporters and High reporters (see Figure 11). Overall, as hypothesized, systemic 
symptom reporting was unrelated to actual Ab response. 
 
3.2 Summary 
 Hypothesis 3 sought to address the unexplained variance in Ab response and State 
NA changes by examining a number of potential moderating and mediating factors in the 
relationship between State NA and Ab response. Neither stress domain – psychogenic or 
systemic – acted as a moderator in the relationship between State NA and Ab response 
(Model I). Systemic symptom reporting, however, acted as both an independent factor and a 
mediator (Model II), depending upon the temporal reference. Systemic symptom reporting 
strengthened the relationship between Ab response and changes in State NA in 1992, and 
acted as a mediator between Ab response to both Beijing strains and depression in 1996. Yet 
further investigations showed that systemic symptom reporting was unrelated to actual 
immune activation. Thus, it appears that while baseline State NA acted as a good predictor 
of Ab response independent of the potential exogenous explanatory factors postulated, the 
afferent relationship between immune activation and alterations appears sensitive to 
somatization.  
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Hypothesis 4: Positive affect, PA, will be associated with enhanced Ab response to 
influenza inoculation.   
 Although supporting evidence is scarce, some work indicates that PA associates with 
more robust immunity. Hence, it is hypothesized that high PA will predict greater Ab 
response to inoculation. 
 
4.1 Associations between Positive Affect and Ab Response to Influenza Inoculation 
 Separate analyses were run to assess whether the two components of PA, optimism 
and mood, were associated with Ab response to the individual strains. As with Trait NA, 
both cross-sectional and longitudinal assessments were made.   
 
4.1.1 Cross-sectional Associations between Trait PA and Ab Response 
 Positive mood and optimism showed significant positive associations with one 
another throughout the study (p<0.001). While PA showed no associations with Ab 
response to any strain in the first and last years of the study (see Tables 18 and 19, 
respectively), 1993 Ab response did show associations with Positive mood. Positive mood 
was significantly positively associated with Ab slope to the Beijing89 and Beijing92 strains, and 
showed a trend toward significance to Taiwan (see Table 20). Thus, as Positive mood 
increases, so does Ab responsiveness to these strains in 1993. Again, although positive mood 
and optimism were highly correlated, optimism showed no such association with Ab 
response, indicating a dissociation of the effect of the two measures of PA on Ab response. 
 Univariate ANOVA was used to further clarify the relationship between PA, 
particularly Positive mood and Ab response in 1993, and to identify whether any interactive 
effects between the two PA measures would be unmasked. When Positive mood was 
49 
 
categorized into groups, associations did not remain for four of the strains in 1993 (Beijing89: 
F(2,143)=1.794, p=0.170; Beijing92: F(2,143)=1.380, p=0.255; Taiwan: F(2,143)=0.810, 
p=0.447). Positive mood did show a significant association with Ab response to Texas¸ 
F(2,143)=3.470, p=0.034, with Moderate Positive mood showing the greatest Ab response. 
A significant interaction effect between Optimism and Positive mood on Taiwan response in 
1992 was also uncovered, F(4,143)=2.701, p=0.033. It appears that having a High level of 
either Optimism or Positive mood results in an enhanced Ab response to Taiwan in 1992, 
and High levels of both aspects of PA shows one of the most robust responses with the least 
variability (see Figure 12). Also, Positive mood shows a trend toward associating with Taiwan 
responsiveness in 1996, F(2,143)=2.434, p=0.091, with Low Positive mood showing reduced 
Ab response (see Figure 13). Together these results, while not overwhelmingly compelling, 
appear to reveal that Positive Affect may have an enhancing effect on Ab response, again, in 
a strain-dependent manner. 
 
4.1.2 Longitudinal Associations between PA and Ab Response 
 Level of Optimism remained stable across years, F(2,150)=0.426, p=0.631, and 
repeated measures ANOVA revealed no long-term associations between Optimism and Ab 
response to any of the strains (p>0.50).  Positive mood was not a stable attribute, however, 
as it gradually but significantly declined over the course of the study, F(2,150)=17.429, 
p<0.001 (see Figure 14). As such, Positive mood was across years converted to a slope, and 
generalized linear regression was used to examine the relationship between Positive mood 
and Ab response over the span of the study. Unfortunately, Positive mood showed no long-
term relationship with Ab response to any of the strains (p>0.25). To ensure that an 
interaction between the two measures was not accounting for this lack of effect, when 
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Optimism was added to the model, results were not altered. Overall, while Positive mood 
may have some weak immediate associations with Ab response to some strains, neither 
measure of PA appears to have long-term immunological consequences. 
 
4.2 Summary 
 It was posited that heightened PA would have an enhancing effect on Ab response. 
As hypothesized, increases in positive mood (though not optimism) tended to associate with 
enhanced Ab response in a strain-specific manner in 1993. No associations were observed in 
1992 or 1996. Positive affect showed no long-term impact on Ab response in longitudinal 
investigations. Hence, although there appears to be a transient enhancing effect of positive 
mood on immunity, the long-term effects of PA are not compelling. As PA was a Trait 
construct (due to lack of PA assessments during immunization), effects may have been more 
evident by measuring PA as a state construct (as with NA).    
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DISCUSSION 
 This series of investigations sought to add to the existing literature by delineating the 
dynamic cross-sectional and long-term interactions between affective states, stress exposure, 
and immunity subsequent to immunological challenge in a healthy, elderly sample. In 
attempting to create a more holistic perspective of this dynamic situation, we examined both 
efferent pathways from the CNS to the immune system, as well as afferent pathways from 
immune activation to affective state. Also, we examined whether Trait versus State affective 
qualities would differentially equate with immunity.  
 
Trait NA and Immunity 
 The first hypothesis speculated that Trait negative affect (depression and anxiety), as 
a stable personality attribute, would be unrelated to either cross-sectional or longitudinal Ab 
response to influenza inoculation. This hypothesis was largely supported, in that no cross-
sectional associations were observed, and only one influenza strain associated longitudinally 
with Trait NA. Given the unexpectedness of the finding that degree of Trait anxiety was 
associated with varying patterns of long-term Ab response to the Panama strain, we sought to 
identify potential extraneous variables. Even after controlling for the effects of stress (both 
psychogenic and systemic) and State anxiety, the relationship between Trait anxiety and 
Panama responsiveness remained. While this does not preclude that existence of another, 
unaccounted for, variable is mediating this relationship, it does appear to indicate that Trait 
anxiety (but not depression) may have antigen-dependent influences on Ab response to 
inoculation. Overall, that Trait NA does not act as a good predictor of Ab responsiveness is 
consistent with prior research demonstrating that Trait, relative to State, NA is a poor 
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predictor of somatic complaint consequent to benign immune activation (Leventhal et al., 
1996).  
 
Dynamic interplay between State NA and Immunity 
 Unlike Trait NA, it was posited that State NA, as a more direct index of stress 
reactivity, would have a dynamic relationship with immune activation to influenza 
inoculation. Specifically, we formulated that baseline State NA would act in an efferent 
manner to influence Ab response, in that high levels of baseline State NA would reflect a 
heightened stress response to inoculation, and this would in turn lead to reductions in Ab 
response (possibly via an HPA-driven mechanism). The attenuated Ab response associated 
with high baseline NA would afferently elicit fewer overt symptoms and physiological signals 
of immune activation, hence alleviating follow-up NA in those with high levels of baseline 
NA. As such, low Ab response would be positively associated with decreases in NA from 
baseline to follow-up, whereas robust Ab response would be associated with elevations in 
State NA. Contrary to expectations, high baseline depression and anxiety, at times 
independently and at other times in concert with one another, predicted enhanced Ab 
response in a year- and strain-specific manner. Only poorer Ab response to Taiwan in 1996 
consequent to high baseline anxiety supported the hypothesis. These unexpected findings 
suggest that reconceptualizations of the "value judgments" of initial NA are in order. High 
levels of initial NA did not predict impaired immunity, but instead robust response. It is 
possible that although baseline State NA was high, it may have diminished rapidly after the 
stress of inoculation, hence reflecting not a pathological affective response but a rational 
reaction to the situation, thus having no adverse impact on immunity.  
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 While it was expected that lower follow-up Ab titer/less robust response (slope) 
would predict a reduction in NA, the opposite relationship generally emerged. Contrary to 
hypotheses, elevated Ab titer at two weeks post-inoculation predicted decreased state anxiety 
and depression, particularly the first year of the study. As before, and consistent with the 
commonsense framework, initial affective reactivity may have been high, but once the 
immediate stressor had passed individuals soon returned to a lower state of NA, hence the 
relationship observed. All associations disappeared the subsequent year, but in 1996 changes 
in Ab response then predicted alterations in State depression in a similar manner as in 1992. 
Strain- and year-specific effects again emerged, and furthermore the two means of 
quantifying Ab response dissociated from one another in their impact on changes in state 
NA. While slope exhibited the predicted direction of effects (positive associations) for 
follow-up State anxiety subsequent to Beijing92 Ab response, it was also a less consistent 
predictor than titer, which showed the unexpected negative associations with follow-up State 
NA. The slope measure is more theoretically sound, in that the baseline Ab titer is taken into 
account in the dependent measure itself (though accounting for baseline Ab titer did not 
alter results). And since the two-week follow-up time point is sub-optimal in an elderly 
sample, who generally show a four-week delay of peak Ab response (Levine et al., 1987), the 
slope findings may have been stronger and more consistent if the four-week time point was 
assayed. Since the two measures of Ab response (slope and titer value) had paradoxical 
associations with NA (in spite of baseline titer being accounted for), this illuminates the 
importance of considering how this dependent measure is quantified when making cross-
study comparisons. Also, as the most consistent effects were observed the first year, it is 
likely that the novelty of initial exposure produced the most robust relationships between Ab 
response and follow-up State NA. In both models of the relationship between State NA and 
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Ab response, the posited factors accounted for maximally 50% variability in the dependent 
measure (either Ab response or State NA change), and as such, this indicates that other 
factors influenced both variability of Ab response and alterations in state NA during the 
time of immune activation.  
 
Stress and Systemic Symptom Reporting as Potential Moderators/Mediators 
 Given the degree of unexplained variance in the dependent measures of Ab response 
and State NA change subsequent to immune activation, we sought to identify possible 
moderators and/or mediators. Since stress is know to influence both affect (Leventhal et al., 
1998) and immune function (Kiecolt-Glaser et al., 1996), it was posited that stress would 
likely act as a moderator. Stress was conceptualized under two domains: psychogenic 
(stressful life events) and systemic (existence of a chronic, non-immunological illness). This 
strategy was employed in order to tap both the emotional and physiological aspects of stress, 
and as such to examine its potential efferent and afferent consequences. Systemic symptom 
reporting was also included as a potential mediator in the afferent relationship between Ab 
response and follow-up State NA, as it was likely that the degree to which participants 
experience inoculation-based symptoms would influence their subjective NA state. 
Surprisingly, neither stress domain, psychological nor systemic, acted as a moderator in the 
efferent relationship between baseline State NA and Ab response. Systemic symptom 
reporting, however, acted as both an independent factor and a mediator in the relationship 
between Ab response and follow-up State NA, depending upon the temporal reference. 
Systemic symptom reporting strengthened the relationship between Ab response and 
changes in State NA in 1992, and acted as a mediator between Ab response to both Beijing 
strains and depression in 1996. Yet further investigations showed that systemic symptom 
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reporting was unrelated to actual immune activation. Thus, it appears that while baseline 
State NA acted as a sound predictor of Ab response independent of the potential exogenous 
explanatory factors postulated, the afferent relationship between immune activation and 
emotional response appears sensitive to somatization. 
 
Long-Term Associations between State NA and Ab Response  
 Longitudinal analyses revealed a complex interactive picture of the relationship 
between follow-up State NA tendency and Ab response profile, and provided a broader 
context in which to place the cross-sectional results. There is a dynamic relationship, 
depending on State NA reactivity, strain, and time that is masked in cross-sectional 
investigations, indicating the danger of making sweeping generalities from a single sampling 
point. The most dramatic findings were related to Beijing92, Taiwan, and Panama strain 
responses and the interaction between both dimensions of follow-up State NA. The Ab 
response profile of robust initial response followed by steady decreases over the years was 
associated with combinations of no change in one dimension of NA and decreases in the 
other. Initially high levels of follow-up NA also contributed to the subsequent declines over 
the years. This pattern was most consistent in those with no change in anxiety and decreases 
in depression. Interestingly, none of the individuals who showed "no change" in follow-up 
State NA over the years exhibited low levels of either depression or anxiety, hence they 
existed in a static condition of moderate or high levels of NA, and inflexible affective styles 
have been associated with poorer health outcomes (Rozanski and Kubzansky, 2005). Given 
how large the Ab response was that first year, it likely represents not an efficient response 
but a potentially maladaptively excessive one.  
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Positive Affect and Immunity 
 Though supported by far fewer studies, it was posited that higher levels of PA would 
have an enhancing effect on Ab response. As hypothesized, increases in positive mood 
(though not optimism) tended to cross-sectionally associate with enhanced Ab response in a 
strain-specific manner during the second year of the study. Positive affect showed no long-
term impact on Ab response in longitudinal investigations. Hence, although there appears to 
be a transient enhancing effect of positive mood on immunity, the long-term effects of PA 
are not compelling. As PA was a Trait construct, effects may have been more evident by 
measuring PA as a State construct (as was observed with NA, and which has been found in 
prior studies, Cohen et al 2003b).    
 
The Strain Effect 
 Far more difficult to explain and justify with supporting literature are the profoundly 
different findings dependent upon influenza strain. Though other investigators have also 
found similar strain-specific effects (Vedhara et al., 1999; Miller et al., 2004; Pressman et al., 
2005), the precise explanation for them has been elusive. It is known that influenza A viruses 
have greater genetic variability and are associated with greater mortality (Mak et al., 2006). 
Hence, the differences in virus type may account for some of the variability in our findings. 
As such, certain individuals may be genetically predisposed toward inoculation 
responsiveness, depending on strain mutations. Furthermore, certain strains are 
phylogentically "older" and hence individuals, particularly elderly individuals with a long 
history of possible exposure, have increased likelihood of prior encounters with these strains. 
Lastly, some strains may bear closer antigenic resemblance to one another than others (for 
example, Beijing and Harbin are antigenically indistinguishable (Li et al., 2008)), thus resulting 
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in equivalent Ab response. Importantly, in this study design antibodies for each strain were 
assayed every year even if they were not an inoculation component at that time. Hence, 
Beijing89 and Taiwan Ab responses subsequent to 1991 reflected a memory response, non-
inoculation exposure, and/or epitope similarity to another strain. Texas was the only strain 
consistently present in the inoculant. While the experimental ideal would have been to 
deliver novel antigen at each annual inoculation time point, even if this were possible 
antigenic overlap and inability to accurately assess prior exposure history would still render 
interpretation questionable.  
 
Limitations  
 There are certain considerations that must be made when interpreting the findings in 
this study. The nature of the population from which we drew our sample posed some 
challenges. Due to recidivism and the morbidity expectant in an elderly population, our 
sample size was restricted. However, there was only a participant loss of approximately 3% 
each year, which is a low rate considering the extensive nature of the study. The nature of 
the study sample also posed drawbacks and strengths. For the most part, this sample 
represented a fairly homogenous group in terms of socioeconomic status, education, age, 
and ethnicity. While this may limit the generalizability of findings to the elderly population at 
large, it also controls for the potential extraneous effects of these variables. Also, although it 
was not ideal to include participants with comorbid chronic disease states, excluding would 
have prevented obtaining the sample size necessary to detect effects. Moreover, examining 
how the presence of an additional (non-immunological) systemic stressor interacted with 
both the systemic challenge of inoculation and NA to modulate immune activity was an 
important element of this scientific query. Surprisingly, neither dimension of stress (systemic 
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or psychogenic) acted as a moderator in the relationships amongst NA and immune activity. 
It is possible, and indeed likely, that other psychosocial factor (i.e., quality of life, activity 
level, social support networks, and/or loneliness) may have acted as moderators in these 
relationships. Though beyond the scope of the present endeavor, future studies should 
incorporate these factors.  
 Methodologically, while the HAIA is not as sensitive as other measures (i.e., ELISA), 
it provided the enhanced specificity necessary when considering epitope similarity and strain-
specific effects, which were extensively found in the present study. More importantly than 
technique, the follow-up time point for examining Ab response was sub-optimal for this 
sample, as older individuals often show delay of peak response until four weeks post-
inoculation (Levine et al., 1987). Stronger and additional findings may have been elicited had 
the four-week follow-up time point been used. Furthermore, subjective characterization of 
an "appropriate" antibody response is highly debatable. While the four-fold increase in titer 
from baseline is the accepted minimum to be considered "responsive," the opposite end of 
what constitutes a deleteriously high level of antibody response is subject to great debate. As 
elderly individuals generally show diminished immunity, one may extrapolate that any 
amount of increase over the median would be advantageous. However, it is unclear as to 
whether there exists an antibody response that is excessively high. This may indeed be the 
case in younger population samples, as the potential for cross-reactivity between strains and 
exaggerated antibody response has the potential to result in autoimmune consequences; 
however, this likelihood is negligible in elderly samples. Also, unfortunately cortisol was not 
measured. Measures of cortisol would have been a meaningful index of neuroendocrine 
activity and may have been a more objective measure of stress reactivity than self-reports, 
especially as it has been shown that changes in glucocorticoids can inhibit immunoglobulin 
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production (Besedovsky and del Rey, 2007). Thus, while it cannot be ruled out that the 
pathway between State NA and altered Ab response is mediated by cortisol, Miller and 
colleagues (2004) found that cortisol did not act as a mediator between stress and Ab 
response in a young sample.  
 
Conclusions 
 Now we arrive at the crucial question: What does this all practically mean? 
Essentially, the practical implications for these diverse findings suggest that certain healthy 
elderly individuals, with certain affective and immunological tendencies exhibit certain 
emotional and physiological responses to certain stimuli at certain points in time. While this 
may be an unsatisfyingly vague statement from a reductionist perspective, it accurately 
reflects not only the findings of the present study, but also what occurs in the natural 
environment. No two individuals exposed to the same stimulus will react, either emotionally 
or physiologically, in an identical manner. While the presence of pathogen is necessary to 
induce immune activation, it is not necessarily sufficient to produce physical manifestations 
of illness, and factors such as genetic susceptibility, environmental circumstances, threat 
perception and coping mechanisms are just a few factors that combine to determine 
disruption/maintenance of homeostasis subsequent to pathogen exposure (Ader, 1980). 
Though patterns may emerge (such as the tendency for elevated Ab response to predict 
decreases in follow-up State NA), there are a constellation of factors at play, some to a 
greater and some to a lesser degree, which dictate individual differences. It is precisely this 
individual variability (in exposure, experience, affective tendency, coping abilities, support 
structures) which forms the essence of psychosomatic research endeavors. As Robert Ader 
so eloquently stated in his 1980 Presidential address to the American Psychosomatic Society, 
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"Despite the most sophisticated strategies designed to achieve uniformity, variability remains 
one of the most ubiquitous results of all natural and contrived biological experiments" (p. 
307). For the purposes of interpretation and intervention strategy implementation, it would 
have been ideal to find consistent, systematic relationships amongst NA, PA and Ab 
response to influenza inoculation supporting the hypotheses. However, what this study 
illustrates quite elegantly is the complexities involved in investigating the relationship 
between health and immunity, and importantly sheds light on how varying temporal, 
antigenic, and quantification strategies may elicit substantially differing findings. As such, this 
study adds considerably to the body of work exploring the dynamic interplay between 
emotion, experience, aging, and physiological response to benign immune challenge.  
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TABLE CAPTIONS 
Table 1. Annual influenza vaccination viral components. 
 
Table 2. Correlations between Trait NA and Ab response slope in 1992. Significant 
correlations highlighted in yellow. 
 
Table 3. Correlations between Trait NA and Ab response slope in 1993. Significant 
correlations highlighted in yellow. 
 
Table 4. Correlations between Trait NA and Ab response slope in 1996. Significant 
correlations highlighted in yellow.  
  
Table 5. Correlations between long-term changes in follow-up State NA and Ab response. 
Significant correlations highlighted in yellow.  
 
Table 6. Correlations between State NA and psychological stress (life events) in 1992. 
Significant correlations highlighted in yellow. 
 
Table 7. Correlations between State NA and psychological stress (lie events) in 1993. 
Significant correlations highlighted in yellow. 
 
Table 8. Correlations between State NA and psychological stress (life events) in 1996. 
Significant correlations highlighted in yellow. 
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Table 9. Correlations between State NA and systemic stress (chronic illness) in 1992. 
Significant correlations highlighted in yellow. 
 
Table 10. Correlations between State NA and systemic stress (chronic illness) in 1993. 
Significant correlations highlighted in yellow. 
 
Table 11. Correlations between State NA and systemic stress (chronic illness) in 1996. 
Significant correlations highlighted in yellow. 
 
Table 12. Correlations between State NA (both score at follow-up and slope of change from 
baseline), stress, and systemic symptom reports in 1992. Significant correlations highlighted 
in yellow. Trends toward significance highlighted in blue. 
 
Table 13. Correlations between State NA (both score at follow-up and slope of change from 
baseline), stress, and systemic symptom reports in 1993. Significant correlations highlighted 
in yellow. Trends toward significance highlighted in blue. 
 
Table 14. Correlations between State NA (both score at follow-up and slope of change from 
baseline), stress, and systemic symptom reports in 1996. Significant correlations highlighted 
in yellow. Trends toward significance highlighted in blue. 
 
Table 15. Correlations between systemic symptoms and Ab response slope in 1992. 
Significant correlations highlighted in yellow. Trends toward significance highlighted in blue. 
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Table 16. No correlations existed between systemic symptoms and Ab response slope in 
1993.  
 
Table 17. No correlations existed between systemic symptoms and Ab response slope in 
1996.  
 
Table 18. Correlations between PA and Ab response in 1992. Significant correlations 
highlighted in yellow.  
 
Table 19. Correlations between PA and Ab response in 1996. Significant correlations 
highlighted in yellow. 
 
Table 20. Correlations between PA and Ab response in 1993. Significant correlations 
highlighted in yellow. Trends toward significance highlighted in blue. 
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TABLES 
Table 1. Annual influenza vaccination viral components. 
1991 1992 1993 1994 1995 1996 
B/Beijing 
89 
B/Beijing 
92 
B/Beijing 
92 
B/Shandong B/Harbin B/Harbin 
A/Panama  
(H1N1) 
A/Panama 
(H1N1) 
A/Panama 
(H1N1) 
A/Panama 
(H1N1) 
A/Johannesburg 
(H1N1) 
A/Nanchang 
95 (H3N2) 
A/Taiwan 
(H1N1) 
A/Texas 
(H3N2) 
A/Texas 
(H3N2) 
A/Texas 
(H3N2) 
A/Texas 
(H3N2) 
A/Texas 
(H3N2) 
 
Table 2. Correlations between Trait NA and Ab response slope in 1992. 
Correlations
1 .560 -.012 .061 .082 .026
.000 .882 .455 .313 .751
152 152 152 152 152 152
.560 1 -.016 .141 .104 .002
.000 .848 .083 .204 .985
152 152 152 152 152 152
-.012 -.016 1 .226 .224 .266
.882 .848 .005 .005 .001
152 152 152 152 152 152
.061 .141 .226 1 .460 .397
.455 .083 .005 .000 .000
152 152 152 152 152 152
.082 .104 .224 .460 1 .487
.313 .204 .005 .000 .000
152 152 152 152 152 152
.026 .002 .266 .397 .487 1
.751 .985 .001 .000 .000
152 152 152 152 152 152
.055 .026 .343 .483 .381 .366
.497 .751 .000 .000 .000 .000
152 152 152 152 152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
92 Trait dep
92 Trait anx
Be89_92_change_slope
Be92_92_change_slope
Pan92_change_slope
Tai92_change_slope
Tex92_change_slope
92 Trait dep 92 Trait anx
Be89_92_
change_slope
Be92_92_
change_slope
Pan92_change_
slope
Tai92_change_
slope
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Table 3. Correlations between Trait NA and Ab response slope in 1993. 
Correlations
1 .730 .021 -.106 -.053 -.063
.000 .802 .192 .513 .441
152 152 152 152 152 152
.730 1 .032 -.113 -.033 -.075
.000 .699 .165 .689 .361
152 152 152 152 152 152
.021 .032 1 .394 .164 .258
.802 .699 .000 .044 .001
152 152 152 152 152 152
-.106 -.113 .394 1 .068 .072
.192 .165 .000 .403 .381
152 152 152 152 152 152
-.053 -.033 .164 .068 1 .385
.513 .689 .044 .403 .000
152 152 152 152 152 152
-.063 -.075 .258 .072 .385 1
.441 .361 .001 .381 .000
152 152 152 152 152 152
.007 -.031 .309 .273 .163 .253
.934 .703 .000 .001 .044 .002
152 152 152 152 152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
96 Trait dep
96 Trait anx
Be89_96_change_slope
Be92_96_change_slope
Pan96_change_slope
Tai96_change_slope
Tex96_change_slope
96 Trait dep 96 Trait anx
Be89_96_
change_slope
Be92_96_
change_slope
Pan96_change_
slope
Tai96_change_
slope
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Table 4. Correlations between Trait NA and Ab response slope in 1996. 
Correlations
1 .596 -.046 -.066 .091 .022
.000 .573 .419 .266 .792
152 152 152 152 152 152
.596 1 .007 .041 .169 .087
.000 .928 .615 .037 .289
152 152 152 152 152 152
-.046 .007 1 .593 .187 .436
.573 .928 .000 .021 .000
152 152 152 152 152 152
-.066 .041 .593 1 .305 .511
.419 .615 .000 .000 .000
152 152 152 152 152 152
.091 .169 .187 .305 1 .310
.266 .037 .021 .000 .000
152 152 152 152 152 152
.022 .087 .436 .511 .310 1
.792 .289 .000 .000 .000
152 152 152 152 152 152
.013 .155 .332 .534 .447 .269
.870 .057 .000 .000 .000 .001
152 152 152 152 152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
93 Trait dep
93 Trait anx
Be89_93_change_slope
Be92_93_change_slope
Pan93_change_slope
Tai93_change_slope
Tex93_change_slope
93 Trait dep 93 Trait anx
Be89_93_
change_slope
Be92_93_
change_slope
Pan93_change_
slope
Tai93_change_
slope
 
 
 
 
 
 
 
 
 
 
76 
 
Table 5. Correlations between long-term changes in State NA and Ab response. 
Correlations
1 .663
.000
152 152
.663 1
.000
152 152
-.117 -.038
.152 .639
152 152
-.049 -.086
.552 .292
152 152
-.052 -.041
.521 .619
152 152
-.310 -.175
.000 .031
152 152
-.060 -.056
.466 .493
152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Dep2wk_slope
Anx2wk_slope
be89_slope
be92_slope
pan_slope
tai_slope
tex_slope
Dep2wk_
slope
Anx2wk_
slope
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Table 6. Correlations between State NA and psychological stress in 1992. 
Correlations
1 .668 .752 .516
.000 .000 .000
152 152 152 152
.668 1 .557 .696
.000 .000 .000
152 152 152 152
.752 .557 1 .582
.000 .000 .000
152 152 152 152
.516 .696 .582 1
.000 .000 .000
152 152 152 152
.027 -.057 -.013 .048
.741 .496 .880 .563
147 147 147 147
Statistics
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Variables
 (92 BL dep)
(92 2wk dep)
(92 BL anx)
 (92 2w k anx)
Stressor History Sum92
(92 BL dep)  (92 2w k dep)  (92 BL anx) (92 2wk anx)
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Table 7. Correlations between State NA and psychological stress in 1993. 
Correlations
1 .576 .732 .518
.000 .000 .000
152 152 152 152
.576 1 .553 .842
.000 .000 .000
152 152 152 152
.732 .553 1 .625
.000 .000 .000
152 152 152 152
.518 .842 .625 1
.000 .000 .000
152 152 152 152
.029 .051 .021 .069
.726 .538 .796 .400
151 151 151 151
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
(93 BL dep)
 (93 2wk dep)
(93 BL anx)
 (93 2wk anx)
Stressor History
Sum93
 (93 BL dep) (93 2wk dep)  (93 BL anx)  (93 2wk anx)
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Table 8. Correlations between State NA and psychological stress in 1996. 
Correlations
1 .693 .775 .643
.000 .000 .000
152 152 152 152
.693 1 .545 .774
.000 .000 .000
152 152 152 152
.775 .545 1 .692
.000 .000 .000
152 152 152 152
.643 .774 .692 1
.000 .000 .000
152 152 152 152
.093 .025 .109 .045
.255 .759 .182 .580
152 152 152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
(96 BL dep)
(96 2wk dep)
(96 BL anx)
(96 2wk anx)
Stressor History Sum96
(96 BL dep) (96 2wk dep) (96 BL anx) (96 2wk anx)
 
Table 9. Correlations between State NA and systemic stress in 1992. 
Correlations
1 .668 .752 .516
.000 .000 .000
152 152 152 152
.668 1 .557 .696
.000 .000 .000
152 152 152 152
.752 .557 1 .582
.000 .000 .000
152 152 152 152
.516 .696 .582 1
.000 .000 .000
152 152 152 152
.132 .171 .178 .251
.104 .035 .028 .002
152 152 152 152
Statistics
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Variables
 (92 BL dep)
(92 2wk dep)
(92 BL anx)
 (92 2w k anx)
chronic illness Sum92
(92 BL dep)  (92 2w k dep)  (92 BL anx) (92 2wk anx)
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Table 10. Correlations between State NA and systemic stress in 1993. 
Correlations
1 .576 .732 .518
.000 .000 .000
152 152 152 152
.576 1 .553 .842
.000 .000 .000
152 152 152 152
.732 .553 1 .625
.000 .000 .000
152 152 152 152
.518 .842 .625 1
.000 .000 .000
152 152 152 152
.033 -.096 .025 -.077
.689 .241 .759 .343
152 152 152 152
Statistics
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Variables
(93 BL dep)
 (93 2wk dep)
(93 BL anx)
 (93 2wk anx)
 chronic illness Sum93
 (93 BL dep) (93 2wk dep)  (93 BL anx)  (93 2wk anx)
 
Table 11. Correlations between State NA and systemic stress in 1996. 
Correlations
1 .693 .775 .643
.000 .000 .000
152 152 152 152
.693 1 .545 .774
.000 .000 .000
152 152 152 152
.775 .545 1 .692
.000 .000 .000
152 152 152 152
.643 .774 .692 1
.000 .000 .000
152 152 152 152
.109 .066 .140 .060
.181 .416 .085 .461
152 152 152 152
Statistics
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Variables
(96 BL dep)
(96 2wk dep)
(96 BL anx)
(96 2wk anx)
chronic illness Sum96
(96 BL dep) (96 2wk dep) (96 BL anx) (96 2wk anx)
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Table 12. Correlations between State NA, stress, and systemic symptom reports in 1992. 
Correlations
1 .503 .417 .228 -.105 .050
.000 .000 .005 .207 .544
152 152 152 152 147 152
.503 1 .157 .464 .067 .082
.000 .053 .000 .421 .317
152 152 152 152 147 152
.417 .157 1 .696 -.057 .171
.000 .053 .000 .496 .035
152 152 152 152 147 152
.228 .464 .696 1 .048 .251
.005 .000 .000 .563 .002
152 152 152 152 147 152
-.105 .067 -.057 .048 1 -.041
.207 .421 .496 .563 .618
147 147 147 147 147 147
.050 .082 .171 .251 -.041 1
.544 .317 .035 .002 .618
152 152 152 152 147 152
.280 .128 .498 .352 -.025 .161
.000 .116 .000 .000 .763 .048
151 151 151 151 146 151
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
dep92_slope
anx92_slope
92 2wk dep
92 2wk anx
Stressor History 92
chronic illness 92
Systemic symptoms
92 2 weeks
dep92_slope anx92_slope 92 2wk dep 92 2wk anx
Stressor
History 92
chronic illness
92
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Table 13. Correlations between State NA, stress, and systemic symptom reports in 1993. 
Correlations
1 .633 .460 .352 .024 -.139
.000 .000 .000 .774 .087
152 152 152 152 151 152
.633 1 .347 .447 .056 -.119
.000 .000 .000 .494 .145
152 152 152 152 151 152
.460 .347 1 .842 .051 -.096
.000 .000 .000 .538 .241
152 152 152 152 151 152
.352 .447 .842 1 .069 -.077
.000 .000 .000 .400 .343
152 152 152 152 151 152
.024 .056 .051 .069 1 .063
.774 .494 .538 .400 .445
151 151 151 151 151 151
-.139 -.119 -.096 -.077 .063 1
.087 .145 .241 .343 .445
152 152 152 152 151 152
.159 -.005 .410 .304 .098 .013
.050 .948 .000 .000 .233 .871
152 152 152 152 151 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
dep93_slope
anx93_slope
93 2wk dep
93 2wk anx
Stressor History 93
chronic illness 93
Systemic symptoms
93 2 weeks
dep93_slope anx93_slope 93 2wk dep 93 2wk anx
Stressor
History 93
chronic illness
93
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Table 14. Correlations between State NA, stress, and systemic symptom reports in 1996. 
Correlations
1 .588 .396 .170 -.086 -.054
.000 .000 .036 .292 .509
152 152 152 152 152 152
.588 1 .289 .389 -.081 -.102
.000 .000 .000 .319 .209
152 152 152 152 152 152
.396 .289 1 .774 .025 .066
.000 .000 .000 .759 .416
152 152 152 152 152 152
.170 .389 .774 1 .045 .060
.036 .000 .000 .580 .461
152 152 152 152 152 152
-.086 -.081 .025 .045 1 .003
.292 .319 .759 .580 .972
152 152 152 152 152 152
-.054 -.102 .066 .060 .003 1
.509 .209 .416 .461 .972
152 152 152 152 152 152
.067 -.023 .346 .238 .220 .262
.413 .778 .000 .003 .007 .001
151 151 151 151 151 151
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
dep96_slope
anx96_slope
96 2wk dep
96 2wk anx
Stressor History 96
chronic illness 96
Systemic symptoms
96 2 weeks
dep96_slope anx96_slope 96 2wk dep 96 2wk anx
Stressor
History 96
chronic illness
96
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Table 15. Correlations between systemic symptoms and Ab response slope in 1992. 
Correlations
1
151
-.091
.268
151
-.046
.576
151
.000
.997
151
-.028
.734
151
-.144
.077
151
Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Systemic symptoms 92
2 weeks
Be89_92_slope
Be92_92_slope
Pan92_slope
Tai92_slope
Tex92_slope
Systemic
symptoms
92 2 weeks
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Table 16. No correlations existed between systemic symptoms and Ab response slope in 
1993. 
Correlations
1
152
.008
.918
152
-.054
.510
152
.120
.141
152
-.009
.912
152
.032
.692
152
Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Systemic symptoms 93
2 weeks
Be89_93_slope
Be92_93_slope
Pan93_slope
Tai93_slope
Tex93_slope
Systemic
symptoms
93 2 weeks
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Table 17. No correlations existed between systemic symptoms and Ab response slope in 
1996. 
Correlations
1
151
.058
.478
151
.087
.287
151
-.010
.907
151
.102
.211
151
.018
.825
151
Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Systemic symptoms 96
2 weeks
Be89_96_slope
Be92_96_slope
Pan96_slope
Tai96_slope
Tex96_slope
Systemic
symptoms
96 2 weeks
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Table 18. Correlations between PA and Ab response in 1992.  
Correlations
1 .507
.000
152 152
.507 1
.000
152 152
.116 .041
.154 .616
152 152
-.034 .031
.677 .708
152 152
-.017 .045
.834 .582
152 152
-.025 .071
.760 .386
152 152
.047 .000
.568 .996
152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
optimism 92
positive affect 92
Be89_92_slope
Be92_92_slope
Pan92_slope
Tai92_slope
Tex92_slope
optimism
92
positive mood
92
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Table 19. Correlations between PA and Ab response in 1996. 
Correlations
1 .415
.000
152 152
.415 1
.000
152 152
.123 -.057
.133 .485
152 152
.119 .072
.145 .375
152 152
-.036 -.059
.663 .472
152 152
.044 .082
.586 .316
152 152
.034 -.010
.673 .900
152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
optimism 96
positive affect 96
Be89_96_slope
Be92_96_slope
Pan96_slope
Tai96_slope
Tex96_slope
optimism
96
positive mood
96
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Table 20. Correlations between PA and Ab response in 1993. 
Correlations
1 .569
.000
152 152
.569 1
.000
152 152
.119 .257
.143 .001
152 152
.049 .173
.548 .033
152 152
-.029 -.048
.721 .554
152 152
.095 .146
.245 .073
152 152
-.050 .024
.538 .766
152 152
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
optimism 93
positive affect 93
Be89_93_slope
Be92_93_slope
Pan93_slope
Tai93_slope
Tex93_slope
optimism
93
positive mood
93
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FIGURE LEGENDS 
Figure 1. Schematic representation of the communications between neuro-endocrine and 
immune systems. Communication between the CNS and immune system occur via multiple 
routes: vagal afferents, HPA axis, the peripheral nervous system, and both sympathetic and 
parasympathetic branches of the autonomic nervous system. From Sternberg 2006. 
 
Figure 2.  Graphical depiction of both long-loop and local interactions between the immune 
and neuro-endocrine systems. The box depicting the immune system represents not only 
classical immunological organs (i.e., spleen) but also any peripheral tissue in which immune 
responses may take place. Neural and endocrine systems are depicted together due to their 
high degree of interconnectivity. When immune activation at a distant location impacts 
neuro-endocrine functions, this is referred to as "long-loop" interactions, whereas co-
expression of immune and neuro-endocrine factors site-specifically refers to "local" 
interactions (circles within boxes). Branching out arrows symbolize the organismic 
consequences of immune, nervous, and endocrine interactions. From Besedovsky and del 
Rey, 1996. 
 
Figure 3. Trait anxiety groups show distinct long-term immunological profiles to Panama. 
Error bars reflect SEM. X-axis: year; Y-axis: Panama Ab response slope; lines represent Trait 
Anxiety categories.  
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Figure 4. Distinct Beijing92 Ab response profiles were dependent upon follow-up state 
Depression. Error bars reflect SEM. X-axis: year; Y-axis: Beijing92 Ab response slope; lines 
represent Depression categories quantified as whether participants increased, decreased, or 
showed no change in follow-up depression across years. 
 
Figure 5. There was a relationship between follow-up Anxiety change category and Ab 
response to Beijing92. Error bars reflect SEM. X-axis: Anxiety categories quantified as 
whether participants increased, decreased, or showed no change in follow-up anxiety across 
years; Y-axis: Beijing92 Ab response slope. 
 
Figure 6. Interactive effects between follow-up NA response category and long-term Ab 
response to Beijing92. Note: No individuals showed an absence of change in both dimensions 
of NA. Error bars reflect SEM. X-axis: year; Y-axis: Beijing92 Ab response slope; lines 
represent combinations of follow-up State NA (depression and anxiety) categories quantified 
as whether participants increased, decreased, or showed no change in follow-up depression 
across years. 
 
Figure 7. Interactive effects of follow-up NA response category on long-term Ab response 
to Panama. Note: No individuals showed an absence of change in both dimensions of NA. 
Error bars reflect SEM. X-axis: year; Y-axis: Panama Ab response slope; lines represent 
combinations of follow-up State NA (depression and anxiety) categories quantified as 
whether participants increased, decreased, or showed no change in follow-up depression 
across years. 
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Figure 8. Follow-up Depression category and Ab response to Panama. Error bars reflect 
SEM. X-axis: Depression categories quantified as whether participants increased, decreased, 
or showed no change in follow-up depression across years; Y-axis: Panama Ab response 
slope. 
 
Figure 9. There was a relationship between follow-up Anxiety change category and Ab 
response to Taiwain. Error bars reflect SEM. X-axis: Anxiety categories quantified as whether 
participants increased, decreased, or showed no change in follow-up anxiety across years; Y-
axis: Taiwan Ab response slope. 
 
Figure 10. There was a relationship between follow-up Depression change category and Ab 
response to Taiwan. Error bars reflect SEM. X-axis: Depression categories quantified as 
whether participants increased, decreased, or showed no change in follow-up depression 
across years; Y-axis: Taiwan Ab response slope. 
 
Figure 11. Low systemic symptom reporters showed enhanced Ab response to Beijing89 
relative to other groups in 1992. Error bars reflect SEM. X-axis: Systemic symptom 
reporting category quantified as whether participants reported no (Non-reporter), few (Low 
reporter), or many (High reporter) systemic symptoms two weeks after inoculation; Y-axis: 
1992 Beijing89 Ab response slope. 
 
Figure 12. Relationships between PA and Taiwan Ab slope in 1993. Error bars reflect SEM. 
X-axis: PA group categories (combinations of Positive mood and Optimism: Low, Moderate, 
and High); Y-axis: 1993 Taiwan Ab response slope. 
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Figure 13. Low Positive mood tends to show reduced Ab response to Taiwan in 1996. Error 
bars reflect SEM. X-axis: Positive mood category (Low, Moderate, and High); Y-axis: 1996 
Taiwan Ab response slope. 
 
Figure 14. Positive mood decreased significantly over the five years of the study. Error bars 
reflect SEM. X-axis: year; Y-axis: Positive mood sum score. 
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Figure 7. 
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Figure 12. 
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Figure 13. 
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Figure 14. 
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APPENDIX A: MEDICAL EXCLUSIONARY CRITERIA 
1.  DISEASES: 
 Malignancy (solid tumor): 
 <1 year without evidence of active disease 
 <1 year since completion of treatment 
 received chemotherapeutic treatment at any time 
 Leukemia 
 Lymphoma 
 Myeloma 
 Lupus erythematosus 
 Rheumatoid arthritis 
 Polymyalgia rheumatica 
 Temporal arteritis 
 Sjorgren's disease 
 Myasthenia gravis 
 Multiple sclerosis 
 Amyotrophic lateral sclerosis 
 Vasculitis 
 Graves disease 
 Gaucher's disease 
 Chrohn's disease 
 Ulcerative colitis 
 Chronic fatigue immunodeficiency syndrome 
 Hypogammaglobulinemia 
 Hepatitis: <5 years without evidence of active disease 
 Cirrhosis: <5 years without evidence of active disease 
 
2. MEDICATIONS: 
 Antineoplastics 
 Tamoxifen 
 DES 
 Steroids (oral) 
 Aspirin/aspirin compounds: unable to abstain 2 weeks prior to and 4 weeks during 
study 
 NSAIDs: unable to abstain 2 weeks prior to and 4 weeks during study 
 Beta-blockers 
 Lithium  
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